Blue Calypso S-1/A 21 Aug 15 2015 FY IPO registration (amended) Financial data

Document And Entity Information

Document And Entity Information - shares	12 Months Ended
	Jun. 30, 2015	Aug. 03, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	BLUE CALYPSO, INC.
Document Type	S1
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		5,013,366
Amendment Flag	false
Entity Central Index Key	1,399,587
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Document Period End Date	Jun. 30, 2015
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	FY

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)	Jun. 30, 2015	Dec. 31, 2014	Dec. 31, 2013
Current assets:
Cash	$ 74,725	$ 1,103,201	$ 1,294,882
Accounts receivable, net	79,618	167,396	64,300
Prepaid expenses and other current assets	47,912	50,356	57,371
Total current assets	202,255	1,320,953	1,416,553
Property and equipment, net	10,022	6,315	10,009
Other assets:
Deferred offering costs	79,912
Capitalized software development costs, net of accumulated amortization of $1,156,478, $986,502 and $647,247 as of June 30, 2015, December 31, 2014 and 2013, respectively	775,190	794,551	984,674
Total assets	1,067,379	2,121,819	2,411,236
Current liabilities:
Accounts payable	108,139	24,600	161,225
Accrued expenses	107,040	236,526	$ 4,878
Deferred revenue		$ 1,100
Convertible notes payable, net of discount of $207,589 as of December 31, 2013			$ 242,411
Warrant liability			2,030
Total current liabilities	215,179	$ 262,226	410,544
Long term debt:
Convertible notes payable, net of discount of $15,830 as of December 31, 2013			134,170
Total liabilities	215,179	$ 262,226	$ 544,714
Commitments and contingencies
Stockholders' equity:
Preferred stock, $0.0001 par value; 5,000,000 shares authorized: Series A convertible preferred stock, $0.0001 par value; 1,700,000 shares designated; -0-, 161,827 and 750,068 shares issued and outstanding as of June 30, 2015, December 31, 2014 and 2013, respectively		$ 16	$ 75
Common stock, $0.0001 par value; 680,000,000 shares authorized, 5,013,366 , 4,902,639 and 3,764,778 shares issued and outstanding as of June 30, 2015, December 31, 2014 and 2013, respectively	501	490	376
Additional paid in capital	34,323,624	34,026,321	26,297,841
Accumulated deficit	(33,471,925)	(32,167,234)	(24,431,770)
Total stockholders' equity	852,200	1,859,593	1,866,522
Total liabilities and stockholders' equity	$ 1,067,379	$ 2,121,819	$ 2,411,236
Preferred Stock [Member]
Stockholders' equity:
Preferred stock, $0.0001 par value; 5,000,000 shares authorized: Series A convertible preferred stock, $0.0001 par value; 1,700,000 shares designated; -0-, 161,827 and 750,068 shares issued and outstanding as of June 30, 2015, December 31, 2014 and 2013, respectively
Total stockholders' equity		$ 16	$ 75
Series A Convertible Preferred Stock [Member]
Stockholders' equity:
Preferred stock, $0.0001 par value; 5,000,000 shares authorized: Series A convertible preferred stock, $0.0001 par value; 1,700,000 shares designated; -0-, 161,827 and 750,068 shares issued and outstanding as of June 30, 2015, December 31, 2014 and 2013, respectively		$ 16	$ 75

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parentheticals) - USD ($)	Jun. 30, 2015	Dec. 31, 2014	Dec. 31, 2013
Capitalized software development costs,accumulated amortization (in Dollars)	$ 1,156,478	$ 986,502	$ 647,247
Convertible Debt, Discount, Current (in Dollars)			207,589
Convertible Debt, Discount, Non Current (in Dollars)			$ 15,830
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001	$ 0.0001
Common stock,shares authorized	680,000,000	680,000,000	680,000,000
Common stock,shares issued	5,013,366	4,902,639	3,764,778
Common stock, shares outstanding	5,013,366	4,902,639	3,764,778
Preferred Stock [Member]
Preferred stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	5,000,000	5,000,000	5,000,000
Series A Convertible Preferred Stock [Member]
Preferred stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,700,000	1,700,000	1,700,000
Preferred stock, shares issued	0	161,827	750,068
Preferred stock, shares outstanding	0	161,827	750,068

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014	Dec. 31, 2013
REVENUE	$ 109,489	$ 122,032	$ 225,214	$ 286,247	$ 759,889	$ 341,972
Cost of revenue	44,665	71,046	99,777	144,793	412,225	142,755
Gross profit	64,824	50,986	125,437	141,454	347,664	199,217
OPERATING EXPENSES:
Sales and marketing	105,681	144,949	154,255	308,466	482,729	682,600
General and administrative	566,078	1,178,874	1,101,625	2,251,250	6,103,628	4,843,804
Depreciation and amortization	88,154	84,776	172,775	168,191	344,128	300,909
Total operating expenses	759,913	1,408,599	1,428,655	2,727,907	6,930,485	5,827,313
Loss from operations	(695,089)	(1,357,613)	(1,303,218)	(2,586,453)	(6,582,821)	(5,628,096)
Other expense:
Change in fair value of derivative liabilities		487		2,030	2,030	7,630,434
Loss on settlement or conversion inducement of debt					(413,917)	(6,810,982)
Interest expense	(757)	(96,126)	(1,473)	(614,190)	(740,756)	(2,015,145)
Total other expense	(757)	(95,639)	(1,473)	(612,160)	(1,152,643)	(1,195,693)
NET LOSS	$ (695,846)	$ (1,453,252)	$ (1,304,691)	$ (3,198,613)	$ (7,735,464)	$ (6,823,789)
Net loss per common share, basic and diluted (in Dollars per share)	$ (0.14)	$ (0.34)	$ (0.26)	$ (0.78)	$ (1.80)	$ (2.36)
Weighted average common shares outstanding, basic and diluted (in Shares)	4,985,204	4,218,096	4,951,625	4,110,304	4,288,825	2,885,409

CONSOLIDATED STATEMENT OF STOCK

CONSOLIDATED STATEMENT OF STOCKHOLDERS` EQUITY - USD ($)	Accounts Payable [Member]Common Stock [Member]	Accounts Payable [Member]Additional Paid-in Capital [Member]	Accounts Payable [Member]	Convertible Note [Member]Common Stock [Member]	Convertible Note [Member]Additional Paid-in Capital [Member]	Convertible Note [Member]	Conversion of Notes Payable and Accrued Interest into Common stock at $1.50 Per Share [Member]Common Stock [Member]	Conversion of Notes Payable and Accrued Interest into Common stock at $1.50 Per Share [Member]Additional Paid-in Capital [Member]	Conversion of Notes Payable and Accrued Interest into Common stock at $1.50 Per Share [Member]	Conversion of Notes Payable and Accrued Interest into Common stock at $6.50 Per Share [Member]Common Stock [Member]	Conversion of Notes Payable and Accrued Interest into Common stock at $6.50 Per Share [Member]Additional Paid-in Capital [Member]	Conversion of Notes Payable and Accrued Interest into Common stock at $6.50 Per Share [Member]	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2012													$ 170	$ 250	$ 6,565,142	$ (17,607,981)	$ (11,042,419)
Balance (in Shares) at Dec. 31, 2012													1,700,000	2,502,735
Conversion of note payable-former Affiliate to equity														$ 7	553,356		553,363
Conversion of note payable-former Affiliate to equity (in Shares)														73,733
Conversion of preferred shares to common shares													$ (95)	$ 28	67
Conversion of preferred shares to common shares (in Shares)													(949,932)	279,823
Return of shares from Founder														$ (33)	33
Return of shares from Founder (in Shares)														(331,460)
Conversion of notes payable and accrued interest into common stock							$ 40	$ 544,066	$ 544,106	$ 39	$ 2,519,961	$ 2,520,000
Conversion of notes payable and accrued interest into common stock (in Shares)							400,000			388,000
Shares issued in settlement	$ 2	$ 277,037	$ 277,039
Shares issued in settlement (in Shares)	23,561
Reclassification of derivative liabilities to equity															6,384,814		6,384,814
Reclassification of warrants as derivative liabilities															(2,013,972)		(2,013,972)
Loss on debt modification of notes payable															6,810,982		6,810,982
Stock based compensation															551,483		551,483
Beneficial conversion feature associated with notes payable															268,210		268,210
Net loss																(6,823,789)	(6,823,789)
Balance at Dec. 31, 2013													$ 75	$ 376	26,297,841	(24,431,770)	1,866,522
Balance (in Shares) at Dec. 31, 2013													750,068	3,764,778
Shares issued to third party as debt discount in connection with notes payable														$ 3	229,688		229,691
Shares issued to third party as debt discount in connection with notes payable (in Shares)														24,000
Shares issued as deferred financing costs in connection with notes payable														$ 2	171,998		172,000
Shares issued as deferred financing costs in connection with notes payable (in Shares)														20,000
Shares issued to acquire software														$ 2	149,998		$ 150,000
Shares issued to acquire software (in Shares)														20,000			1,000,000
Vesting of restricted stock units (prior year accrual of $872,387)														$ 13	1,784,001		$ 1,784,014
Vesting of restricted stock units (prior year accrual of $872,387) (in Shares)														133,463
Sale of common stock associated with private transaction														$ 23	1,500,977		1,501,000
Sale of common stock associated with private transaction (in Shares)														230,923
Conversion of preferred shares to common shares													$ (59)	$ 17	42
Conversion of preferred shares to common shares (in Shares)													(588,241)	173,267
Net shares cancelled in exchange for option exercise (in Shares)														(222)
Shares issued in settlement				$ 14	$ 549,986	$ 550,000
Shares issued in settlement (in Shares)				139,150
Shares issued as inducement to settle convertible notes															37,345		37,345
Shares issued as inducement to settle convertible notes (in Shares)														4,400
Loss on warrant modification															460,949		460,949
Loss on debt conversion inducement															376,572		$ 376,572
Reclassification of derivative liabilities to equity
Reclassification of warrants as derivative liabilities
Stock based compensation														$ 9	3,731,906		$ 3,731,915
Stock based compensation (in Shares)														88,843
Net loss																(7,735,464)	(7,735,464)
Balance at Dec. 31, 2014													$ 16	$ 490	34,026,321	(32,167,234)	1,859,593
Balance (in Shares) at Dec. 31, 2014													161,827	4,902,639
Shares issued in connection with exercise of warrants														$ 41	1,024,517		1,024,558
Shares issued in connection with exercise of warrants (in Shares)														409,823
Shares issued for services rendered														$ 3	195,465		195,468
Shares issued for services rendered (in Shares)														31,200
Shares issued in connection with exercise of options														$ 1	21,727		21,728
Shares issued in connection with exercise of options (in Shares)														6,400
Sale of common stock associated with private transaction														$ 29	1,329,971		1,330,000
Sale of common stock associated with private transaction (in Shares)														285,000
Conversion of preferred shares to common shares													$ (16)	$ 5	11
Conversion of preferred shares to common shares (in Shares)													(161,827)	47,646
Stock based compensation														$ 4	168,893		168,897
Stock based compensation (in Shares)														43,620
Net loss																(1,304,691)	(1,304,691)
Balance at Jun. 30, 2015														$ 501	34,323,624	$ (33,471,925)	$ 852,200
Balance (in Shares) at Jun. 30, 2015														5,013,366
Shares issued in connection with exercise of warrants (in Shares)
Shares issued for services rendered														$ 2	$ 128,399		$ 128,401
Shares issued for services rendered (in Shares)														19,461

CONSOLIDATED STATEMENT OF STOC6

CONSOLIDATED STATEMENT OF STOCKHOLDERS` EQUITY (Parentheticals)	12 Months Ended
	Dec. 31, 2013USD ($)
Vesting of restricted stock units, accrual	$ 872,387

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended		12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014	Dec. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (1,304,691)	$ (3,198,613)	$ (7,735,464)	$ (6,823,789)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	172,775	168,191	344,128	$ 300,909
Provision for doubtful accounts	19,141		23,762
Amortization of debt discounts		125,550	$ 223,419	$ 751,126
Amortization of deferred financing costs				$ 234,500
Interest from warrant modification		460,949	$ 460,949
Loss on debt conversion inducement			$ 413,917
Loss on settlement of notes payable				$ 6,810,982
Change in fair value of derivative liabilities		(2,030)	$ (2,030)	(7,630,434)
Loss on modification of warrants				1,027,371
Stock based compensation	168,897	1,109,565	$ 3,731,915	$ 2,530,061
Common stock issued for services rendered	128,401	80,000	195,468
Changes in operating assets and liabilities:
Accounts receivable	68,637	(65,287)	(126,857)	$ (20,432)
Prepaid expenses	2,444	35,430	7,015	(54,319)
Accounts payable	83,539	(56,197)	(136,625)	221,821
Accrued expenses	(129,486)	44,396	231,648	(94,697)
Deferred revenue	(1,100)	48,069	1,100	(10,000)
Net cash used in operating activities	(791,443)	$ (1,249,977)	(2,367,655)	$ (2,756,901)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of fixed assets	(6,506)		(1,180)
Software development costs	(150,615)	$ (63,434)	(149,132)	$ (205,515)
Net cash used in investing activities	(157,121)	(63,434)	(150,312)	(205,515)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from sale of common stock			$ 1,330,000	1,501,000
Proceeds from notes payable				2,600,000
Fees paid to third party in connection with notes payable issuance				$ (62,500)
Proceeds from exercise of options		21,728	$ 21,728
Deferred offering costs	(79,912)
Proceeds from exercise of warrants		1,024,558	1,024,558
Repayments of convertible notes payable			(50,000)
Net cash (used) provided by financing activities	(79,912)	1,046,286	2,326,286	$ 4,038,500
Net (decrease) increase in cash	(1,028,476)	(267,125)	(191,681)	1,076,084
Cash at beginning of period	1,103,201	1,294,882	1,294,882	218,798
Cash at end of period	74,725	$ 1,027,757	1,103,201	1,294,882
SUPPLEMENTAL INFORMATION
Cash paid for interest	1,473		$ 29,127	$ 63,510
Cash paid for income taxes
Non-cash investing and financing activities:
Conversion of notes payable and accounts payable-former affiliate to common stock				$ 553,363
Acquisition of technology in exchange for issuance of common stock
Conversion of notes payable to common and preferred stock			$ 550,000	$ 2,915,000
Conversion of accrued interest on notes payable to common stock				149,106
Reclassification of derivative liability to equity				6,384,814
Reclassification of warrants as derivative liability				2,013,972
Shares issued to third party as debt discount on notes payable				229,691
Common stock issued to acquire software				150,000
Issuance of shares as deferred financing costs related to notes payable				172,000
Issuance of stock to settle accounts payable				277,039
Issuance of shares upon conversion of Series A convertible preferred stock	$ 16
Warrant [Member]
Non-cash investing and financing activities:
Fair value of conversion option issued				3,041,342
Convertible Notes Payable [Member]
Non-cash investing and financing activities:
Fair value of conversion option issued				$ 11,930

NATURE OF OPERATIONS AND BASIS

NATURE OF OPERATIONS AND BASIS OF PRESENTATION	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Disclosure Text Block [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	NOTE 1 – NATURE OF OPERATIONS AND BASIS OF PRESENTATION Blue Calypso, Inc., a Delaware corporation (the "Company”), is engaged in the development, sales, delivery, licensing and enforcement of technology and intellectual property focused on mobile shopper engagement and digital word-of-mouth marketing and advertising. In January 2014, the Company transitioned from a development stage enterprise to an operating company. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information. Accordingly, they do not include all of the information and disclosures required by U.S. GAAP for annual financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of the condensed consolidated financial statements of the Company as of June 30, 2015 and for the three and six months ended June 30, 2015 and 2014. The results of operations for the three and six months ended June 30, 2015 are not necessarily indicative of the operating results for the full year ending December 31, 2015, or any other period. These interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related disclosures of the Company as of December 31, 2014 and for the year then ended, which are included elsewhere in this document.	NOTE 1 – NATURE OF OPERATIONS AND BASIS OF PRESENTATION Blue Calypso, Inc. (the “Company”) is engaged in the development, licensing and enforcement of technology and intellectual property focused on digital word-of-mouth marketing and advertising. The Company’s primary activities since inception, have been the design and development of its products, negotiating strategic alliances and other agreements, and raising capital.

REVERSE STOCK SPLIT

REVERSE STOCK SPLIT	6 Months Ended
	Jun. 30, 2015
Reverse Stock Split [Abstract]
Reverse Stock Split [Text Block]	NOTE 1A – REVERSE STOCK SPLIT Effective in the market on July 2, 2015, the Company filed an amendment to its Articles of Incorporation and effected a 50-for-1 reverse stock split of its issued and outstanding shares of common stock, $0.0001 par value, whereby 250,666,631 outstanding shares of the Company’s common stock were exchanged for 5,013,366 shares of the Company's common stock. All per share amounts and number of shares in the consolidated financial statements and related notes have been retroactively restated to reflect the reverse stock split.

GOING CONCERN AND MANAGEMENT'S

GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Substantial Doubt about Going Concern [Text Block]	NOTE 2 –GOING CONCERN AND MANAGEMENT’S LIQUIDITY PLANS As of June 30, 2015, the Company had cash of $74,725 and a working capital deficit of $12,912. During the six months ended June 30, 2015, the Company used net cash in operating activities of $791,443. The Company has incurred net losses since inception. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. On July 20, 2015, the Company issued a senior convertible note with a principal amount of $550,000 (See Note 14) for a purchase price of $500,000. It is anticipated that the proceeds from this note will provide the Company with cash sufficient to fund operations through September 2015. The Company's primary source of operating funds since inception has been cash proceeds from private placements of common stock, preferred stock, convertible debentures and the exercise of warrants. On April 6, 2015, the Company entered into a letter of engagement with a third party firm pursuant to which the firm will act as the sole book runner and lead managing underwriter in connection with a potential registered follow–on offering of common stock or a combination of common stock and warrants. On May 26, 2015, the Company filed a Registration Statement on Form S-1 associated with this potential offering. In conjunction with the potential offering, we have applied for our shares to be listed on a national securities exchange. There can be no assurance that the follow on offering will be completed, that our application to the national securities exchange will be accepted or that funds associated with this potential offering will be available on terms acceptable to the Company, or that the funds from such offering will be sufficient to enable the Company to fully execute its business plan or sustain operations. If the Company is unable to raise sufficient additional funds, it will have to develop and implement a plan to further extend payables, reduce overhead, or scale back its current business plan until sufficient additional capital is raised to support further operations. There can be no assurance that such a plan will be successful. Accordingly, the accompanying condensed consolidated financial statements have been prepared in conformity with U.S. GAAP, which contemplates continuation of the Company as a going concern and the realization of assets and satisfaction of liabilities in the normal course of business. The carrying amounts of assets and liabilities presented in the financial statements do not necessarily purport to represent realizable or settlement values. The condensed consolidated financial statements do not include any adjustment that might result from the outcome of this uncertainty.	NOTE 2 – GOING CONCERN AND MANAGEMENT’S LIQUIDITY PLANS As of December 31, 2014, the Company had cash of $1,103,201 and working capital of $1,058,727. During the year ended December 31, 2014, the Company used net cash in operating activities of $2,367,655. The Company has not yet generated any significant revenues, and has incurred net losses since inception. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. During the year ended December 31, 2014, the Company raised $1,330,000 in cash proceeds from the sale of common stock and $1,046,286 through the exercise of common stock options and warrants. The Company believes that its current cash on hand will be sufficient to fund its projected operating requirements through June 2015. The Company's primary source of operating funds since inception has been cash proceeds from the private placements of common stock and preferred stock, and proceeds from private placements of convertible debt. The Company intends to raise additional capital through private placements of debt and equity securities, but there can be no assurance that these funds will be available on terms acceptable to the Company, or will be sufficient to enable the Company to fully complete its development activities or sustain operations. If the Company is unable to raise sufficient additional funds, it will have to develop and implement a plan to further extend payables, reduce overhead, or scale back its current business plan until sufficient additional capital is raised to support further operations. There can be no assurance that such a plan will be successful. Accordingly, the accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”), which contemplate continuation of the Company as a going concern and the realization of assets and satisfaction of liabilities in the normal course of business. The carrying amounts of assets and liabilities presented in the financial statements do not necessarily purport to represent realizable or settlement values. The consolidated financial statements do not include any adjustment that might result from the outcome of this uncertainty.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the recoverability and useful lives of long-lived assets, the fair value of the Company’s stock, stock-based compensation, debt discounts and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates. Concentrations of Credit Risk As of June 30, 2015, three customers represented 35%, 27% and 18% of the Company’s accounts receivable. As of December 31, 2014, two customers represented 62% and 20% of the Company’s accounts receivable. During the three months ended June 30, 2015, two customers represented 56% and 20% of total revenue. During the six months ended June 30, 2015, three customers represented 60%, 15% and 11% of total revenue. During the three months ended June 30, 2014, three customers represented 57%, 15% and 12% of total revenue. During the six months ended June 30, 2014, three customers represented 46%, 24% and 14% of total revenue. Deferred Offering Costs The Company classifies amounts related to a potential future offering not closed as of the balance sheet date as Deferred Offering Costs. During the six months ended June 30, 2015, the Company capitalized costs in the amount of $79,912 as Deferred Offering Costs in the accompanying condensed consolidated balance sheet. Net Loss per Share The Company computes basic net loss per share by dividing net loss per share available to common stockholders by the weighted average number of common shares outstanding for the period, adjusted to give effect to the 50-for-1 reverse stock split, which was effective in the market on July 2, 2015 (see Note 4), and excludes the effects of any potentially dilutive securities. Diluted earnings per share, if presented, would include the dilution that would occur upon the exercise or conversion of all potentially dilutive securities into common stock using the “treasury stock” and/or “if converted” methods as applicable. The computation of basic and diluted loss per share for the three and six months ended June 30, 2015 and 2014 excludes potentially dilutive securities when their inclusion would be anti-dilutive, or if their exercise prices were greater than the average market price of the common stock during the period. Potentially dilutive securities excluded from the computation of basic and diluted net loss per share are as follows: June 30, 2015 June 30, 2014 Convertible notes payable - 60,000 Series A convertible preferred stock - 220,913 Options to purchase common stock 565,939 517,406 Warrants to purchase common stock 220,913 240,092 Restricted stock units - 88,843 Totals 786,852 1,127,254 Recent Accounting Pronouncements In April 2015, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) Number 2015-3 entitled “Simplifying the Presentation of Debt Issuance Costs.” The new guidance specifies that debt issuance costs under the new standard are to be netted against the carrying value of the financial liability. Under current guidance, debt issuance costs are recognized as a deferred charge and reported as a separate asset on the balance sheet. The new guidance aligns the treatment of debt issuance costs and debt discounts in that both reduce the carrying value of the liability. It is important to note that neither the recognition nor measurement of debt issuance costs is changed as a result of the ASU. Amortization of debt issuance costs is to be recorded as interest expense on the income statement. The effective date of the new guidance is for fiscal years beginning after December 15, 2015, for public business entities and interim periods within those fiscal years. Early adoption is permitted for financial statements that have not been issued previously. The Company does not believe the effect of the adoption of this standard will have a material impact on the Company’s condensed consolidated financial statements. There are other various updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to have a material impact on the Company's financial position, results of operations or cash flows. Subsequent Events The Company evaluates events that have occurred after the balance sheet date but before the financial statements are issued. Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the condensed consolidated financial statements, except as disclosed.	NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. Revenue Recognition Revenue is recognized when persuasive evidence of an arrangement exists, delivery of the product or service has occurred, all obligations have been performed pursuant to the terms of the agreement, the sales price is fixed or determinable, and collectability is reasonably assured. Revenue includes fees received from customers for advertising and marketing service. Revenue is recognized when services are performed or licenses are granted to customers. Revenue from the licensing of the Company’s intellectual property and settlements reached from legal enforcement of the Company’s patent rights is recognized when the arrangement with the licensee has been signed and the license has been delivered and made effective, provided license fees are fixed or determinable and collectability is reasonably assured. The fair value of licenses achieved by ordinary business negotiations is recognized as revenue. The amount of consideration received upon any settlement or judgment is allocated to each element of the settlement based on the fair value of each element. Elements related to licensing agreements, royalty revenues, net of contingent legal fees, are recognized as revenue in the consolidated statement of operations. Elements that are not related to license agreements and royalty revenue in nature will be reflected as a separate line item within the other income section of the consolidated statements of operations. Elements provided in either settlement agreements or judgments include: the value of a license, legal release, and interest. When settlements or judgments are achieved at discounts to the fair value of a license, the Company allocates the full settlement or judgment, excluding specifically named elements as mentioned above, to the value of the license agreement or royalty revenue under the residual method. Legal release as part of a settlement agreement is recognized as a separate line item in the consolidated statements of operations when value can be allocated to the legal release. When the Company reaches a settlement with a defendant, no value is allocated to the legal release since the existence of a settlement removes legal standing to bring a claim of infringement and without a legal claim, the legal release has no economic value. The element that is applicable to interest income will be recorded as a separate line item in other income. The Company does not assume future performance obligations in its license arrangements. Revenue from licensing and related service fees aggregated $23,798 and $245,981 during the years ended December 31, 2014 and 2013. The Company also has revenue from information technology design and programming consulting services. Revenue is recognized in the periods that satisfactory performance of services is delivered to customers. Revenue is recognized when persuasive evidence of an arrangement exists, delivery of the service has occurred, all obligations have been performed pursuant to the terms of the agreement, the sales price is fixed or determinable, and collectability is reasonably assured. Revenue from consulting services was $736,091 and $95,991 during the years ended December 31, 2014 and 2013. Cost of Revenue Legal costs directly related to the settlement of intellectual property and patent enforcement litigation are recognized as cost of revenue. Other legal expenses incurred in the normal course of the Company's business are expensed when incurred as selling, general and administrative expenses. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the recoverability and useful lives of long-lived assets, the fair value of the Company’s stock, stock-based compensation, fair values relating to warrant and other derivative liabilities, debt discounts and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates. Concentrations of Credit Risk The Company’s financial instruments that are exposed to a concentration of credit risk are cash and accounts receivable. As of December 31, 2014, excluding the impact of the allowance for doubtful accounts, two customers represented 62% and 20% of the Company’s accounts receivable. As of December 31, 2013, two customers represented 49% and 24% of the Company’s accounts receivable. During the year ended December 31, 2014, three customers represented approximately 59%, 18% and 10% of total revenue, respectively. During the year ended December 31, 2013, two agreements represented 37% and 29% of total revenue. Cash Cash consist of cash held in bank demand deposits. The Company considers all highly liquid instruments with original maturities of three months or less to be cash equivalents. The Company maintains cash in bank accounts located in the United States, which, at times, may exceed federally insured limits or be uninsured. The Company has not experienced any losses in such accounts. Accounts Receivable Accounts receivable primarily consists of trade receivables, net of allowances. On a periodic basis, the Company evaluates its trade receivables and establishes an allowance for doubtful accounts based on its history of past bad debt expense, collections and current credit conditions. The Company performs on-going credit evaluations of its customers and the customer’s current credit worthiness. Collections and payments from customers are continuously monitored. The Company maintains an allowance for doubtful accounts, which is based upon historical experience as well as specific customer collection issues that have been identified. As of December 31, 2014 and 2013, the Company’s allowance for doubtful accounts was $23,511 and $0, respectively. If the financial condition of customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required in future periods. Property and Equipment Property and equipment consists of office equipment and is recorded at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets, which for office equipment is three to five years. Expenditures for major renewals and betterments that extend the useful lives of the property and equipment are capitalized. Expenditures for maintenance and repairs are charged to expense as incurred. Intangible Assets The Company capitalizes certain software development costs as well as purchased software upon achieving technological feasibility of the related products. Software development costs incurred and software purchased prior to achieving technological feasibility are charged to engineering and product development expense as incurred. Commencing upon initial product release, capitalized costs are amortized to cost of software licenses using the straight-line method over the estimated life of the product (which approximates the ratio that current gross revenues for a product bear to the total of current and anticipated future gross revenues for that product), which is generally up to five years. Impairment of Long-lived Assets The Company reviews the carrying value of intangibles and other long-lived assets for impairment at least annually or whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of long-lived assets is measured by comparing the carrying amount of the asset or asset group to the undiscounted cash flows that the asset or asset group is expected to generate. If the undiscounted cash flows of such assets are less than the carrying amount, the impairment to be recognized is measured by the amount by which the carrying amount of the property, if any, exceeds its fair market value. No impairment was deemed to exist as of December 31, 2014 and 2013. The Company re-evaluates the carrying amounts of its amortizable intangibles at least quarterly to identify any triggering events. As described above, if triggering events require us to undertake an impairment review, it is not possible at this time to determine whether it would be necessary to record a charge or if such charge would be material. Income Taxes The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of items that have been included or excluded in the financial statements or tax returns. Deferred tax assets and liabilities are determined on the basis of the difference between the tax basis of assets and liabilities and their respective financial reporting amounts (“temporary differences”) at enacted tax rates in effect for the years in which the temporary differences are expected to reverse. The Company adopted the provisions of Accounting Standards Codification (“ASC”) Topic 740-10, which prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. Management has evaluated and concluded that there were no material uncertain tax positions requiring recognition in the Company’s consolidated financial statements as of December 31, 2014 and 2013. The Company does not expect any significant changes in its unrecognized tax benefits within twelve months of the reporting date. The Company’s policy is to classify assessments, if any, for tax related interest as interest expense and penalties as general and administrative expenses in the consolidated statements of operations. Net Loss per Share The Company computes basic net income (loss) per share by dividing net income (loss) per share available to common stockholders by the weighted average number of common shares outstanding for the period and excludes the effects of any potentially dilutive securities. Diluted earnings per share, if presented, would include the dilution that would occur upon the exercise or conversion of all potentially dilutive securities into common stock using the “treasury stock” and/or “if converted” methods as applicable. The computation of basic and diluted loss per share as of December 31, 2014 and 2013 excludes potentially dilutive securities when their inclusion would be anti-dilutive, or if their exercise prices were greater than the average market price of the common stock during the period. Potentially dilutive securities excluded from the computation of basic and diluted net income (loss) per share are as follows: December 31, 2014 December 31, 2013 Convertible notes payable - 60,000 Series A convertible preferred stock 47,666 220,913 Options to purchase common stock 441,055 277,551 Warrants to purchase common stock 220,913 649,915 Restricted stock units 43,619 269,133 Totals 753,253 1,477,512 Preferred Stock Preferred shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. The Company classifies conditionally redeemable preferred shares, which includes preferred shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control, as temporary equity. At all other times, the Company classifies its preferred shares in stockholders’ equity. As of December 31, 2014 and 2013, the Company does not have any preferred shares subject to mandatory or conditional redemption outstanding. Convertible Instruments GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional, as that term is described under applicable GAAP. When the Company has determined that the embedded conversion options should not be bifurcated from their host instruments, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption. The Company also records, when necessary, deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the transaction and the effective conversion price embedded in the preferred shares. Common Stock Purchase Warrants and Other Derivative Financial Instruments The Company classifies as equity any contracts that (i) require physical settlement or net-share settlement or (ii) provide the Company with a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement) providing that such contracts are indexed to the Company's own stock. The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the Company’s control) or (ii) gives the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). The Company assesses classification of its common stock purchase warrants and other free standing derivatives at each reporting date to determine whether a change in classification between equity and liabilities is required. The Company’s free-standing derivatives consisted of warrants to purchase common stock that were issued in connection with its private placement transactions (see Note 4) and embedded conversion options with convertible notes. The Company evaluated these derivatives to assess their proper classification in the consolidated balance sheets using the applicable classification criteria enumerated under GAAP. The Company determined that certain common stock purchase warrants and the embedded conversion features do not contain fixed settlement provisions. The exercise price of such warrants is subject to adjustment in the event that the Company subsequently issues equity securities or equity linked securities with exercise prices lower than the exercise price in these warrants. The convertible notes contained a conversion feature such that the Company could not ensure it would have adequate authorized shares to meet all possible conversion demands. As such, the Company was required to record the warrants and debt derivatives which do not have fixed settlement provisions as liabilities and mark to market all such derivatives to fair value at the end of each reporting period. The Company has adopted a sequencing policy that reclassifies contracts (from equity to assets or liabilities) with the most recent inception date first. Thus any available shares are allocated first to contracts with the most recent inception dates. Stock-Based Compensation The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. For employees and directors, the fair value of the award is measured on the grant date and for non-employees, the fair value of the award is generally re-measured on vesting dates and interim financial reporting dates until the service period is complete. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. Stock-based compensation expense is recorded by the Company in the same expense classifications in the consolidated statements of operations, as if such amounts were paid in cash. Advertising The Company's advertising costs are expensed as incurred. Advertising expense was $2,280 and $13,589 for the years ended December 31, 2014 and 2013. Accrued expenses: Accrued expenses were comprised of the following: December 31, 2014 December 31, 2013 Payroll $ 169,965 $ 4,878 Legal and accounting services 39,103 - Interest and other 27,458 - Accrued expenses $ 236,526 $ 4,878 Recent Accounting Pronouncements The FASB has issued ASU No. 2014-12, Compensation – Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period . This ASU requires that a performance target that affects vesting, and that could be achieved after the requisite service period, be treated as a performance condition. As such, the performance target should not be reflected in estimating the grant date fair value of the award. This update further clarifies that compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the period(s) for which the requisite service has already been rendered. The amendments in this ASU are effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. Earlier adoption is permitted. The Company has not yet determined the effect of the adoption of this standard and it is expected to have a material impact on the Company ’ s consolidated financial statements. The FASB has issued ASU No. 2014-09, Revenue from Contracts with Customers . This ASU supercedes the revenue recognition requirements in Accounting Standards Codification 605 - Revenue Recognition and most industry-specific guidance throughout the Codification. The standard requires that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. This ASU is effective on January 1, 2017 and should be applied retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying the ASU recognized at the date of initial application. The Company has not yet determined the effect of the adoption of this standard and it is expected to have an immaterial impact on the Company ’ s consolidated financial statements. In August, 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements – Going Concern (Subtopic 205-40): Disclosure of Uncertainties About an Entities Ability to Continue as a Going Concern. The standard is intended to define management’s responsibility to decide whether there is substantial doubt about an organization’s ability to continue as a going concern and to provide related footnote disclosures. The standard requires management to decide whether there are conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued. The standard provides guidance to an organization’s management, with principles and definitions that are intended to reduce diversity in the timing and content of disclosures that are commonly provided by organizations in the footnotes. The standard becomes effective in the annual period ending after December 15, 2016, with early application permitted. The adoption of this pronouncement is not expected to have a material impact on the consolidated financial statements. Management’s evaluations regarding the events and conditions that raise substantial doubt regarding the Company’s ability to continue as a going concern have been disclosed in Note 2. There are other various updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on the Company's financial position, results of operations or cash flows. Subsequent Events The Company evaluates events that have occurred after the balance sheet date but before the financial statements are issued. Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the consolidated financial statements, except as disclosed.

FAIR VALUE OF FINANCIAL INSTRUM

FAIR VALUE OF FINANCIAL INSTRUMENTS	12 Months Ended
	Dec. 31, 2014
Fair Value Disclosures [Abstract]
Fair Value Disclosures [Text Block]	NOTE 4 - FAIR VALUE OF FINANCIAL INSTRUMENTS The Company measures the fair value of financial assets and liabilities based on the guidance of ASC 820 “Fair Value Measurements and Disclosures” which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value: Level 1 — quoted prices in active markets for identical assets or liabilities Level 2 — quoted prices for similar assets and liabilities in active markets or inputs that are observable Level 3— inputs that are unobservable based on an entity’s own assumptions, as there is little, if any, related market activity. (for example, cash flow modeling inputs based on assumptions) The Company did not have any financial liabilities which were required to be measured at fair value on a recurring basis as of December 31, 2014. Financial liabilities as of December 31, 2013 measured at fair value on a recurring basis are summarized below: December 31, Quoted Prices Significant Significant Derivative liabilities $ 2,030 $ - $ - $ 2,030 The Company determined that the warrants issued in connection with certain financing transactions and certain conversion options related to convertible notes did not have fixed settlement provisions and are deemed to be derivative financial instruments, since the exercise prices were subject to adjustment based on certain subsequent equity issuances. Accordingly, the Company was required to record such warrants and conversion option as liabilities and mark all such derivatives to fair value each reporting period. Such instruments were classified within Level 3 of the valuation hierarchy. The fair value of the warrants and the conversion options was calculated using a binomial lattice formula with the following weighted average assumptions during the years ended December 31, 2014 and 2013: December 31, 2014 December 31 , 2013 Dividend Yield 0.00% 0.00% Volatility 78.94% 80.34% to 85.43% Risk-free Interest Rate 0.07% 0.10% -1.71% Term 0.66 – 0.68 years 0.90 – 3.5 years The risk-free interest rate is the United States Treasury rate on the measurement date having a term equal to the remaining contractual life of the instrument. The volatility is a measure of the amount by which the Company’s share price has fluctuated or is expected to fluctuate. Since the Company’s common stock has not been publicly traded for a long period of time, an average of the historical volatility of comparative companies was used. The dividend yield is 0% as the Company has not made any dividend payment and has no plans to pay dividends in the foreseeable future. Level 3 liabilities are valued using unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the derivative liabilities. For fair value measurements categorized within Level 3 of the fair value hierarchy, the Company’s Chief Financial Officer, who reports to the Chief Executive Officer, determines valuation policies and procedures. Level 3 financial liabilities consist of the derivative liabilities for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate. Significant observable and unobservable inputs include stock price, exercise price, annual risk free rate, term, and expected volatility, and are classified within Level 3 of the valuation hierarchy. An increase or decrease in volatility or interest free rate, in isolation, can significantly increase or decrease the fair value of the derivative liabilities. Changes in the values of the derivative liabilities are recorded as a component of other income (expense) on the Company’s consolidated statements of operations. The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial liabilities that are measured at fair value on a recurring basis for the years ended December 31, 2014 and 2013: Balance-January 1, 2013 $ 10,964,006 Aggregate fair value of derivative instruments issued 3,053,272 Transfers out due to the expiration and modification of derivative aspect of financial instrument (6,384,814) Change in fair value of derivative liabilities (7,630,434) Balance – December 31, 2013 2,030 Change in fair value of derivative liabilities (2,030) Balance – December 31, 2014 $ -

PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	NOTE 5 – PROPERTY AND EQUIPMENT Property and equipment include the following: December 31, 2014 December 31, 2013 Office Equipment $ 24,961 $ 23,781 Less: Accumulated depreciation (18,646) (13,772) Property and equipment, net $ 6,315 $ 10,009 Depreciation expense was $4,874 and $6,619 for the years ended December 31, 2014 and 2013, respectively.

INTANGIBLE ASSETS

INTANGIBLE ASSETS	12 Months Ended
	Dec. 31, 2014
Disclosure Text Block [Abstract]
Intangible Assets Disclosure [Text Block]	NOTE 6 – INTANGIBLE ASSETS Intangible assets consist of the following: December 31, 2014 December 31, 2013 Capitalized Software Development Costs $ 1,781,053 $ 1,631,921 Less: Accumulated amortization (986,502) (647,247) Net capitalized development costs $ 794,551 $ 984,674 During the year ended December 31, 2013, the Company issued 1,000,000 shares of its common stock valued at $150,000 to acquire certain software technology. The shares were valued based upon the volume weighted average price of the Company’s stock price for the thirty days prior to the closing of the transaction. The Company recorded the fair value of the shares issued as an intangible asset with an estimated useful life of 5 years. Amortization expense relating to the capitalized development costs was $339,255 and $294,290 for the years ended December 31, 2014 and 2013, respectively. The estimated future amortization of intangible assets over the remaining weighted average useful life of approximately 4 years is as follows: 2015 $ 333,974 2016 242,323 2017 130,656 2018 69,694 Thereafter 17,904 Total $ 794,551

NOTES PAYABLE

NOTES PAYABLE	12 Months Ended
	Dec. 31, 2014
Disclosure Text Block [Abstract]
Long-term Debt [Text Block]	NOTE 7 – NOTES PAYABLE April 12, 2012 Senior Secured Convertible Debentures From April 2012 through January 2013, the Company issued senior secured convertible debentures (the “Secured Convertible Debentures”) in exchange for an aggregate cash proceeds of $515,000 ($50,000 of which were received on January 15, 2013). The Secured Convertible Debentures had a stated interest rate of 8% per annum, were due on June 30, 2013 and were originally convertible into shares of the Company’s common stock at the option of the holder at a conversion price equal to the closing price of the Company’s common stock on the date of the conversion. The Company identified an embedded derivative related to a conversion option in the Secured Convertible Debentures. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivative as of the inception date of the Secured Convertible Debentures and to fair value the derivative as of each subsequent reporting date. During the year ended December 31, 2013, the holder of the Secured Convertible Debentures converted the aggregate principal amount of $515,000 and accrued interest and fees aggregating $30,764 into 400,000 shares of common stock. Concurrently with this transaction, a shareholder cancelled 257,727 shares of his common stock, which were being held in escrow pursuant to an escrow agreement between the shareholder and the Company. In connection with the debt modification, the Company recorded a loss on debt modification of $5,459,582 representing the difference between the fair value of the aggregate shares issuable under the new conversion price and the original conversion terms of the Secured Convertible Debenture during the year ended December 31, 2013. November 9, 2012 Exchange Agreement On November 9, 2012, the Company entered into the exchange agreement with Aztec Systems, Inc (“Aztec”), pursuant to which the Company and Aztec agreed to exchange a promissory note with a balance of $368,059 and the Company's existing accounts payable to Aztec of $177,899 for an 8% Convertible Note in the original principal amount of $545,958. The 8% Convertible Note was due on March 31, 2013. Pursuant to the exchange agreement, the Company agreed to register the shares of Common Stock issuable upon conversion of the 8% Convertible Note and an aggregate of 74,669 shares of Common Stock currently held by Aztec on or before December 31, 2012. The 8% Convertible Note is convertible into shares of the Company's Common Stock at a conversion price equal to the greater of: (i) $7.50 per share or (ii) the price per share at which Common Stock is sold in a subsequent financing. Upon effectiveness of the registration statement covering the resale of such shares, the 8% Convertible Note will automatically convert into shares of the Company's Common Stock at the applicable conversion price. The aggregate grant date fair value of the common stock was applied to the principal amount of the May 2013 Debenture to determine the debt discount. Accordingly, the Company allocated $229,691 of the proceeds to the relative fair value of the common stock on the grant date and recorded such amount as a debt discount on the date of the transaction. A discount of $341,224 was recorded at issuance and amortization expense of $244,705 was recognized for the year ended December 31, 2013. Upon effectiveness of the registration statement on February 12, 2013, the 8% Convertible Note and accrued interest, in the aggregate amount of approximately $550,000 automatically converted at the fixed conversion price of $7.50 per share into an aggregate of 73,733 shares of the Company’s common stock. November 15, 2012 Unit Offering On November 15, 2012, the Company commenced a private offering of up to $3,000,000 of units (the "Units") at a purchase price of $50,000 per unit pursuant to the securities purchase agreement dated November 15, 2012 (the “Purchase Agreement”). Each Unit consisted of a 10% Convertible Debenture in the principal amount of $50,000 (the “10% Debenture”) and 250 shares of the Company’s common stock. The 10% Debenture bears interest at a rate of 10% per annum, is due two years from the issuance date and is convertible into shares of the Company’s common stock at a conversion price of $10.00 per share. Through December 31, 2012, we issued and sold an aggregate of 9 units totaling $450,000. The 10% Debentures were determined to have an embedded beneficial conversion feature (“BCF”) under the provisions of ASC 470-20, “Debt with Conversion and Other Options” (“ASC 470-20”) based on the issue date market value and the exercise price of $10.00 per share. In accordance with ASC 470-20, a discount of $225,000 was recorded at issuance in 2012 based on the relative fair value of the instruments. During the year ended December 31, 2013 an additional $150,000 of 10% Debentures were issued. An additional discount of $268,210 was recorded in 2013. Amortization expense of $223,419 and $267,272 was recorded during the years ended December 31, 2014 and 2013, respectively. The note balance was $376,581 net of discount of $223,419 at December 31, 2013. On November 10, 2014, the Company modified certain terms of the November 2012 Debentures maturing prior to December 31, 2014 in order to induce the holder to extend the November 2012 Debentures to December 31, 2014. In exchange, the Company provided for a reduction in the conversion price of the November 2012 Debenture to $4.00 per share. In December 2014, the Company entered into exchange agreements with the holders of such debentures pursuant to which the Company exchanged the debentures maturing on December 31, 2014 for new debentures maturing on December 31, 2015. Each debenture holder also received an additional 550 shares of common stock for each $50,000 in principal amount of debentures converted. In December 2014, the Company modified certain terms of the November 2012 Debentures maturing subsequent to December 31, 2014 in order to reduce the conversion price to $3.83 per share. The holders elected to convert the convertible debentures of $550,000 for an aggregate of 143,550 shares of the Company’s common stock. In accordance with ASC 470-20, the fair value of the consideration was measured and recognized as an expense on the dates the inducement offer was accepted by the holder. In connection with the inducement, the Company recorded a loss of $413,917 representing the difference between the fair value of the aggregate shares issuable under the new conversion price and issuance of additional shares as compared to the original conversion feature of the November 2012 Debentures. In December 2014, the Company repaid the remaining $50,000 of principal outstanding under the November 2012 Convertible Debentures and related accrued interest. May 6, 2013 Convertible Debentures On May 6, 2013, the Company issued a convertible debenture in exchange for cash proceeds of $2,400,000 (the “May 2013 Debenture”). The May 2013 Debenture bears interest at a rate of 10% per annum, is due two years from the issuance date and is convertible into shares of the Company’s common stock at the option of the holder at a conversion price of $12.50 per share. In connection with the issuance of the May 2013 Debenture, the Company granted the holder an aggregate of 24,000 shares of common stock with a grant date fair value of $254,400. The aggregate grant date fair value of the common stock was applied to the principal amount of the May 2013 Debenture to determine the debt discount. Accordingly, the Company allocated $229,691 of the proceeds to the relative fair value of the common stock on the grant date and recorded such amount as a debt discount on the date of the transaction. On September 13, 2013, the Company modified certain terms of the May 2013 Debenture in order to induce the holder to convert the May 2013 Debenture into shares of the Company’s common stock as well as to eliminate certain restrictive covenants in the May 2013 Debenture. In exchange, the Company provided for a temporary reduction in the conversion price of the May 2013 Debenture to $6.50 per share through December 31, 2013, after which the conversion price would revert back to the original conversion price of $12.50 per share. In December 2013, the holder elected to convert the convertible debenture of $2,400,000 and related accrued interest of $120,000 at the conversion price of $6.50 per share for an aggregate of 388,000 shares of the Company’s common stock. In accordance with ASC 470-20, the fair value of the consideration was measured and recognized as an expense on the date that the inducement offer is accepted by the holder. In connection with the debt modification, the Company recorded a loss on debt modification of $1,351,400 representing the difference between the fair value of the aggregate shares issuable under the new conversion price and the original conversion terms of the May 2013 Debenture. During the year ended December 31, 2013, the Company recognized $229,691 in amortization of the deferred debt discount relating to the May 2013 Debenture. In connection with the May 2013 Debenture, the Company incurred fees payable to a third party aggregating $62,500, and issued an aggregate of 20,000 shares with a grant date fair value of $172,000 to a third-party. Such amounts were recognized as Deferred Financing Costs on the date of the transaction, and were amortized over the term of the May 2013 Debenture. During the year ended December 31, 2013, the Company recognized $234,500 in amortization of the deferred financing costs relating to the May 2013 Debenture.

WARRANT DERIVATIVE LIABILITIES

WARRANT DERIVATIVE LIABILITIES	12 Months Ended
	Dec. 31, 2014
Warrant Derivative Liability [Abstract]
Warrant Derivative Liability [Text Block]	NOTE 8 - WARRANT DERIVATIVE LIABILITIES The Company issued warrants in conjunction with the issuance of convertible debentures and the sale of Series A Convertible Preferred and Common Stock. These warrants contained certain reset provisions. Therefore, in accordance with ASC 815-40 , the Company classified the fair value of the warrant as a liability at the date of issuance. Subsequent to the initial issuance date, the Company is required to adjust the warrant to fair value as an adjustment to current period operations. On April 19, 2013, the reset provisions of an aggregate of 441,826 warrants which were previously classified as derivative liabilities expired. Accordingly, the fair value at the date of expiration of $4,027,945 was reclassified from liabilities to equity. On April 29, 2013, in connection with an amendment to the Secured Convertible Debentures, the Company reinstated the reset provisions of an aggregate of 220,913 warrants and extended their term from August 31, 2016 to April 30, 2018. The fair value of the modified warrants of $3,041,342 was recorded as a liability with $2,013,972 reclassified from equity (based on original terms) and $1,027,381 charged to 2013 interest (based on term modifications). The fair values were determined using the binomial lattice model. On September 13, 2013, in connection with an amendment to the Secured Convertible Debentures, the Company modified the terms of 220,913 warrants as described above, 58,910 warrants issued on March 31, 2012 and 130,000 warrants issued on April 12, 2012, reducing the exercise prices from $5.00 per share to $2.50 per share; and eliminating the embedded reset provisions. Accordingly, the Company determined the change in fair values of $64,017 to current period expense and reclassified the adjusted liability to equity of $2,356,869. The fair values were determined using the binomial lattice model. As of December 31, 2014, all warrants with embedded reset provisions had expired. (See Note 4).

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	NOTE 4 – STOCKHOLDERS ’ EQUITY Effective June 26, 2015 at the state level and July 2, 2015 in the market, the Company filed an amendment to its Articles of Incorporation and effected a 50-for-1 reverse stock split of its issued and outstanding shares of common stock, $0.0001 par value, whereby 250,666,631 outstanding shares of the Company’s common stock were exchanged for 5,013,366 shares of the Company's common stock. All per share amounts and number of shares in the condensed consolidated financial statements and related notes and other items have been retroactively restated to reflect the reverse stock split resulting in the transfer of $24,024 from common stock to additional paid in capital at December 31, 2014. On March 3, 2015, 161,827 shares of the Company’s Series A Convertible Preferred Stock were converted into an aggregate of 47,646 shares of common stock at the stated conversion price of $3.395 per share. During the six months ended June 30, 2015, the Company issued 8,188 shares of its common stock as consideration for investor relations services valued at $60,000. During the six months ended June 30, 2015, the Company issued 11,273 shares of its common stock as consideration for legal services valued at $68,401. Options Option valuation models require the input of highly subjective assumptions. The fair value of stock-based payment awards was estimated using the Black-Scholes option model with a volatility figure derived from using the Company’s historical stock prices for 2015. Prior to 2015, the Company derived the volatility figure from an index of historical stock prices for comparable entities. Management determined this assumption to be a more accurate indicator of value. The Company accounts for the expected life of options based on the contractual life of options for non-employees. For employees, the Company accounts for the expected life of options in accordance with the “simplified” method, which is used for “plain-vanilla" options, as defined in the accounting standards codification. The risk-free interest rate was determined from the implied yields of U.S. Treasury zero-coupon bonds with a remaining life consistent with the expected term of the options. In addition, the Company is required to estimate the expected forfeiture rate and only recognize expense for those shares expected to vest. In estimating the Company’s forfeiture rate, the Company analyzed its historical forfeiture rate, the remaining lives of unvested options, and the number of vested options as a percentage of total options outstanding. If the Company’s actual forfeiture rate is materially different from its estimate, or if the Company reevaluates the forfeiture rate in the future, the stock-based compensation expense could be significantly different from what the Company has recorded in the current period. The Company estimated forfeitures related to option grants at a weighted average annual rate of 0% per year, as the Company does not yet have adequate historical data, for options granted during the three and six months ended June 30, 2015 and 2014. The following assumptions were used in determining the fair value of employee and vesting non-employee options during the three and six months ended June 30, 2015 and 2014: June 30, 2015 June 30, 2014 Risk-free interest rate 1.68% - 2.07% 2.13% - 2.73% Dividend yield 0% 0% Stock price volatility 123.45%-145.24% 77.6% - 79.2% Expected life 5 - 10 years 8-10 years Weighted average grant date fair value $5.98 $5.50 In January 2015, the Company granted options to purchase 7,500 shares of common stock to a new board member. These options vest over a 3 year period, have a term of 10 years, and contain an exercise price of $5.00 per share. The options had an aggregate grant date fair value of $34,945. In April 2015, the Company granted options to purchase 80,000 shares of common stock to board members. These options vest beginning June 30, 2015 through March 31, 2018 on a quarterly basis, have a term of 10 years and contain an exercise price of $7.00 per share. The options had an aggregate grant date fair value of $493,774. In May 2015, the Company granted an option to purchase 10,000 shares of common stock to a consultant. These options vest beginning June 30, 2015 through March 31, 2017 on a quarterly basis, have a term of 10 years and contain an exercise price of $7.00 per share. The options had an aggregate grant date fair value of $52,049. In May 2015, the Company granted an option to purchase 1,000 shares of common stock to an employee. These options vest over three years on the grant date anniversary, have a term of 10 years and contain an exercise price of $6.50 per share. The options had an aggregate grant date fair value of $5,570. In May 2015, the Company granted an option to purchase 20,000 shares of common stock to a new board member. These options vest beginning June 30, 2015 through March 31, 2018 on a quarterly basis, have a term of 10 years and contain an exercise price of $7.00 per share. The options had an aggregate grant date fair value of $128,115. In June 2015, the Company granted options to purchase 8,000 shares of common stock to four consultants. These options vest beginning June 30, 2015 through March 31, 2018 on a quarterly basis, have a term of 10 years and contain an exercise price of $7.00 per share. The options had an aggregate grant date fair value of $41,688. The following table summarizes the stock option activity for the six months ended June 30, 2015: Weighted Remaining Contractual Term Weighted-Average Exercise Price Aggregate Intrinsic Value Shares Outstanding at January 1, 2015 441,064 $ 8.44 4.2 $ 858,766 Granted 126,500 $ 6.88 10.0 Canceled/expired (1,625) $ 5.73 Outstanding at June 30, 2015 565,939 $ 8.09 4.9 $ 118,486 Exercisable at June 30, 2015 344,683 $ 8.05 3.7 $ 110,570 The following table presents information related to stock options at June 30, 2015: Options Outstanding Options Exercisable Weighted Average Remaining Life In Years Exercisable Number of Options Exercise Price Number of Options $ 0.00-5.00 165,081 4.0 149,247 5.01-12.50 375,449 5.3 174,494 12.51-25.00 15,008 4.7 15,008 25.01-45.00 10,401 4.7 5,934 565,939 4.9 344,683 As of June 30, 2015, stock-based compensation of $747,826 remains unamortized and is expected to be amortized over the weighted average remaining period of 3 years. The stock-based compensation expense related to option grants was $112,744 and $168,897 during the three and six months ended June 30, 2015, respectively, and $157,828 and $233,545 during the three and six months ended June 30, 2014, respectively. Restricted Stock As of June 30, 2015, the Company did not have any unissued restricted shares. Stock based compensation expense related to restricted stock grants was $-0- for the three and six months ended June 30, 2015, and $438,010 and $876,020 for the three and six months ended June 30, 2014, respectively. Warrants The following table summarizes the warrant activity for the six months ended June 30, 2015: Weighted-Average Remaining Contractual Term Aggregate Intrinsic Value Weighted-Average Exercise Price Shares Outstanding at January 1, 2015 220,913 $ 5.00 1.7 $ 1,325,478 Grants - $ - Exercised - Forfeitures or expirations - Outstanding at June 30, 2015 220,913 $ 5.00 1.2 $ 110,457 Exercisable at June 30, 2015 220,913 $ 5.00 1.2 $ 110,457	NOTE 9 – STOCKHOLDERS’ EQUITY Common Stock During the year ended December 31, 2013 the Company’s founder cancelled 331,460 shares of common stock from an escrow as part of an agreement to facilitate financing for the Company. During the year ended December 31, 2013, 949,932 shares of the Company’s Series A Convertible Preferred Stock were converted into an aggregate of 279,823 shares of common stock at the stated conversion price of $3.40 per share. During the year ended December 31, 2013, the Company issued an aggregate of 23,561 shares of common stock to consultants valued at approximately $277,039 for services previously rendered. The issuance was related to 28,561 granted shares and 5,000 shares that were cancelled. In two private placement transactions which closed on October 7, 2013 and October 15, 2013, an aggregate of 230,923 shares of common stock were sold at $6.50 per share for total proceeds of $1,501,000. On January 9, 2014, the Company entered into agreements with the holder of certain of its outstanding warrants originally issued in private placement transactions in September 2011 and April 2012. Pursuant to such agreements, which are more fully described below, the Company agreed to extend the period during which the warrants were exercisable at a reduced exercise price. On January 9, 2014, the Company entered into Amendment No. 4 to the warrants that were originally issued in September 2011. Pursuant to Amendment No. 4, the exercise price of the warrants was reduced to $2.50 per share until March 10, 2014. On January 9, 2014, the Company entered into Amendment No. 3 to the warrant that was originally issued in April 19, 2012. Pursuant to Amendment No. 3, the exercise price of the warrants was reduced to $2.50 per share until March 10, 2014. On January 10, 2014, holders of such warrants exercised an aggregate of 224,000 warrants to purchase common stock at the reduced exercise price per share of $2.50 resulting in $560,000 in cash proceeds. In connection with the warrant exercise, the Company incurred a non-cash interest expense due to warrant modification of $241,176 when the inducement offer was accepted during the year ended December 31, 2014. On March 10, 2014, aggregate of 185,823 of such warrants were exercised resulting in $464,558 in cash proceeds. The Company issued such shares to the holder in April 2014. In connection with the warrant exercise, the Company incurred a non-cash interest expense due to warrant modification of $219,773 when the inducement offer was accepted during the year ended December 31, 2014. During the year ended December 31, 2014, the Company issued an aggregate of 22,154 shares of its common stock as consideration for investor relations services valued at $130,000. During the year ended December 31, 2014, the Company issued an aggregate of 9,046 shares of its common stock as consideration for legal services valued at $65,468. On August 18, 2014, pursuant to a securities purchase agreement, the Company sold an aggregate of 285,000 shares of its common stock for net proceeds, after commissions and other costs, of $1,330,000. Commissions and other costs totaled $95,000. On December 12, 2014, 588,241 shares of the Company’s Series A Convertible Preferred Stock were converted into an aggregate of 173,267 shares of common stock at the stated conversion price of $3.40 per share. On December 31, 2014, Bill Ogle, our former Chief Executive Officer, returned to treasury, and subsequently canceled, 2,222 shares of the Company’s common stock valued at $10,000 as payment for the exercise price of 2,000 previously granted options. Documents associated with the transaction were executed during December 2014 with actual shares issued during January 2015. The related impact on outstanding shares has been recognized as of December 31, 2014. Long-Term Incentive Plan The stockholders approved the Blue Calypso, Inc. 2011 Long-Term Incentive Plan (the “Plan”) on September 9, 2011. The Plan provides for the granting of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, dividend equivalent rights, and other awards which may be granted singly, in combination, or in tandem, and which may be paid in cash or shares of common stock. Subject to certain adjustments, the maximum number of shares of common stock that may be delivered pursuant to awards under the Plan is 700,000 shares. Options Option valuation models require the input of highly subjective assumptions. The fair value of stock-based payment awards was estimated using the Black-Scholes option model with a volatility figure derived from an index of historical stock prices of comparable entities until sufficient data exists to estimate the volatility using the Company’s own historical stock prices. Management determined this assumption to be a more accurate indicator of value. The Company accounts for the expected life of options based on the contractual life of options for non-employees. For employees, the Company accounts for the expected life of options in accordance with the “simplified” method, which is used for “plain-vanilla” options, as defined in the accounting standards codification. The risk-free interest rate was determined from the implied yields of U.S. Treasury zero-coupon bonds with a remaining life consistent with the expected term of the options. The fair value of stock-based payment awards during the years ended December 31, 2014 and 2013 was estimated using the Black-Scholes pricing model. In addition, the Company is required to estimate the expected forfeiture rate and only recognize expense for those shares expected to vest. In estimating the Company’s forfeiture rate, the Company analyzed its historical forfeiture rate, the remaining lives of unvested options, and the number of vested options as a percentage of total options outstanding. If the Company’s actual forfeiture rate is materially different from its estimate, or if the Company reevaluates the forfeiture rate in the future, the stock-based compensation expense could be significantly different from what the Company has recorded in the current period. The Company estimated forfeitures related to option grants at a weighted average annual rate of 0% per year, as the Company does not yet have adequate historical data, for options granted during the years ended December 31, 2014 and 2013. The following assumptions were used in determining the fair value of employee and vesting non-employee options: December 31, 2014 December 31, 2013 Risk-free interest rate 1.97%-2.73% 0.62%-0.86% Dividend yield 0% 0% Stock price volatility 76%-79% 35%-118% Expected life 6-10 years 6-10 years Weighted average grant date fair value $5.50 $5.50 During the year ended December 31, 2013, the Company granted options to purchase an aggregate of 113,171 shares of common stock to certain employees and consultants. These options vest over a 2 or 3 year period, have a term of 10 years, and contain exercise prices between $7.00 and $12.00 per share. The options had an aggregate grant date fair value of $614,342. On March 14, 2014, the Compensation Committee of the Board of Directors approved an equity bonus for the Company’s Co-Chief Executive Officer, Bill Ogle, consisting of stock options with a fair value of $800,000. The total bonus awarded was $1,140,000 of which $85,000 was paid in cash and $1,055,000 was granted in stock options valued using the Black Scholes model. Accordingly, the Company granted options to purchase 184,655 shares of common stock to Mr. Ogle effective March 14, 2014 exercisable at $7.00 per share for ten years, vesting over a term of three years. Subsequent to issuance and pursuant to a standstill agreement entered into on September 26, 2014 with a significant stockholder, Mr. Ogle agreed to return and cancel 15,000 of the previously granted March 2014 options and purchase $85,000 in the Company’s common stock within 12 months following the date of the agreement, with $15,000 being purchased by December 15, 2014. In conjunction with the standstill agreement, Mr. Ogle and the Co-Chief Executive Officer and Chief Technology Officer Andrew Levi agreed to a fifty percent reduction in their annual base salary for a period of twelve months following the date of the agreement. In April 2014, the Company awarded an aggregate of 34,600 of stock options to certain employees and one contractor. The stock options have exercise prices from $6.00 to $6.50 per share, will vest over a three year period, and have an approximate fair value of $170,000 using the Black Scholes model. On April 9, 2014, 6,400 options were exercised at $3.395 per share for cash proceeds of $21,728. In May 2014, the Company awarded an aggregate of 25,000 of stock options to members of the Company’s Board of Directors. The stock options have exercise price of $5.00 per share, will vest over a three year period, and have an approximate fair value of $101,000 using the Black Scholes model. In June 2014, the Company awarded an aggregate of 2,000 of stock options to certain employees. The stock options have exercise price of $5.50 per share, will vest over a three-year period, and have an approximate fair value of $9,000 using the Black Scholes model. On August 15, 2014, the Company’s Board of Directors approved accelerating to fully vested previously granted options of the Company’s past Chief Financial Officer and to set an expiry date of August 15, 2017. Accordingly, the remaining unrecognized expense was charged to operations during the year ended December 31, 2014. On October 23, 2014, the Company’s Board of Directors approved accelerating to fully vested previously granted options of the Company’s past Chief Operating Officer and to set an expiry date of December 31, 2017. Accordingly, the remaining unrecognized expense was charged to operations during the year ended December 31, 2014. Effective December 31, 2014, the Company’s Board of Directors approved the continued vesting of previously granted options through April 30, 2016 of the Company’s former Chief Executive Officer and to set an expiry date of December 31, 2017. Options that would not have vested through April 30, 2016 were considered forfeited as of December 31, 2014. Accordingly, the remaining unrecognized expense related to the non-forfeited options was charged to operations during the year ended December 31, 2014. During December 2014, the Board of Directors appointed a new Board Member, Mr. Jon Merriman. In conjunction with his appointment, the Board of Directors also approved granting Mr. Merriman 7,500 options. As of December 31, 2014 the associated option agreement had not been finalized. No expense associated with this transaction has been reported for the year ended December 31, 2014 and any amount is considered de minimus. The following table summarizes the stock option activity for the years ended December 31, 2014 and 2013: Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term Aggregate Intrinsic Value Shares Outstanding at January 1, 2013 189,211 $ 12.540 9.35 $ - Grants 113,171 $ 11.585 10.00 $ - Exercised - Forfeitures or expirations (24,830) $ 41.500 Outstanding at January 1, 2014 277,552 $ 9.570 8.7 $ 259,558 Grants 246,255 $ 6.500 10.00 $ - Exercised (8,400) Forfeitures or expirations (74,352) 8.115 Outstanding at December 31, 2014 441,055 $ 8.435 4.2 $ 858,766 Exercisable at December 31, 2014 227,263 $ 8.110 4.3 $ 573,899 The following table presents information related to stock options at December 31, 2014: Options Outstanding Options Exercisable Weighted Average Remaining Life In Years Exercisable Number of Options Exercise Price Number of Options $ 0.00-5.00 157,581 4.6 138,831 5.50-12.50 258,074 3.7 67,499 13.00-25.00 15,000 7.4 15,000 25.50-45.00 10,400 5.2 5,933 441,055 4.1 227,263 As of December 31, 2014, stock-based compensation of $164,541 remains unamortized and is expected to be amortized over the weighted average remaining period of 2 years. The stock-based compensation expense related to option grants was $1,250,113 and $551,483 during the years ended December 31, 2014 and 2013, respectively Restricted Stock The following table summarizes the restricted stock activity for the two years ended December 31, 2014: Restricted shares issued as of January 1, 2013 269,133 Granted - Total Restricted Shares Issued at December 31, 2013 269,133 Granted - Total Restricted Shares Issued at December 31, 2014 269,133 Vested at December 31, 2014 (225,514) Unvested restricted shares as of December 31, 2014 43,619 Stock based compensation expense related to restricted stock grants was $2,478,124 and $1,784,014 for the years ended December 31, 2014 and 2013, respectively. As of December 31, 2014, there was no stock-based compensation relating to restricted stock unamortized, since the remaining unamortized expense was charged to operations upon the departure of the Company’s former Chief Executive Officer in December 2014. Warrants The following table summarizes information with respect to outstanding warrants to purchase common stock of the Company, all of which were exercisable, at December 31, 2014: Exercise Price Number Outstanding Expiration Date $ 5.00 220,913 August 2016 . The following table summarizes the warrant activity for the two years ended December 31, 2014: Weighted-Average Remaining Contractual Term Aggregate Intrinsic Value Weighted-Average Exercise Price Shares Outstanding at January 1, 2013 649,915 $ 3.85 4.4 $ - Issued - Exercised - Forfeitures or expirations - Outstanding at January 1, 2014 649,915 $ 3.85 3.4 $ - Grants - $ - Exercised (409,823) $ 2.50 Forfeitures or expirations (19,179) $ 31.00 Outstanding at December 31, 2014 220,913 $ 2.50 1.7 $ 1,325,478 Exercisable at December 31, 2014 220,913 $ 2.50 1.7 $ 1,325,478

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	NOTE 5 – RELATED PARTY TRANSACTIONS The Company appointed a new Chief Financial Officer during August 2014. The Company Mr. D. Jonathan Merriman was appointed to the Company’s Board of Directors during December 2014. Mr. Merriman is the CEO of Merriman Capital, Inc. (“Merriman”). Merriman provides capital market advisory services to the Company for which we incurred expense of $30,000 and $60,000 during the three and six months ended June 30, 2015, respectively. The Company primarily issues common stock in exchange for monthly services and no amount was due to Merriman at June 30, 2015.	NOTE 10 – RELATED PARTY TRANSACTIONS Aztec was an affiliate of the Company that provided administrative and technical support services to the Company. The majority owner of Aztec was also the majority stockholder of the Company until the sale of Aztec on June 15, 2012. During the year ended December 31, 2013, Aztec converted convertible debentures aggregating $522,891 and accrued interest aggregating approximately $30,000 into 73,733 shares of common stock. Concurrently with this issuance a shareholder cancelled 73,733 shares of his common stock and returned them to the Company. During the year ended December 31, 2013, the Company recorded amortization of the debt discount relating to this note aggregating approximately $254,162. The Company appointed a new Chief Financial Officer during August 2014. Blue Calypso utilizes Assure Professional, LLC (“Assure”) to provide certain outsourced accounting services. The Company’s current Chief Financial Officer is a partial owner of Assure. The Company incurred expense of $29,940 in exchange for these services during the year ended December 31, 2014. Included in accounts payable at December 31, 2014 was $2,250 due to Assure. Mr. D. Jonathan Merriman, joined the Company’s Board of Directors during December 2014. Mr. Merriman is the CEO of Merriman Capital, Inc. (“Merriman”). Merriman provides capital market advisory services to the Company for which we incurred expense of $120,000 during the year ended December 31, 2014. In addition, Merriman Capital advised the Company in connection with its August 2014 private placement and received an advisory fee of $95,000. The Company primarily issues common stock in exchange for monthly services and no amount was due to Merriman at December 31, 2014.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	NOTE 6 – COMMITMENTS AND CONTINGENCIES Litigation On July 31, 2012, the Company filed suit against Groupon, Inc. in the Eastern District of Texas in Civil Action No. 6:12-cv-00486. The Company filed additional suits against IZEA, Inc. on October 17, 2012, Yelp, Inc. on October 17, 2012, and Foursquare Labs, Inc. on October 31, 2012 in Civil Action Nos. 6:12-cv-786, 6:12-cv-788, 6:12-cv-837, respectively. Each of these cases alleges that the defendants infringe U.S. Patent Nos. 7,664,516 entitled "Method and System for Peer-to-Peer Advertising Between Mobile Communication Devices" and 8,155,679 entitled "System and Method for Peer-to-Peer Advertising Between Mobile Communication Devices." The Company subsequently added U.S. Patent Nos. 8,438,055, 8,452,646, and 8,457,670 to the cases, alleging each defendant infringed the newly added patents. Each of the defendants have answered, denying infringement and claiming that the asserted patents are invalid. Groupon, Yelp, and Foursquare filed counterclaims for declaratory judgment that the asserted patents are invalid and not infringed. Yelp filed an additional counterclaim for declaratory judgment that the asserted patens are unenforceable. The Court subsequently consolidated the actions for at least pre-trial purposes. Groupon filed a motion to transfer the case against it to the U.S. District Court for the Northern District of Illinois, which the Court denied on September 27, 2013. On February 3, 2014, Groupon filed a petition to the U.S. Court of Appeals for the Federal Circuit for mandamus on the district court's denial of its motion to transfer. On April 23, 2014, the petition was denied by the Federal Circuit. Between July 19, 2013 and October 3, 2013, Groupon filed petitions with the Patent Trial & Appeals Board (“PTAB”) requesting institution of Covered Business Method Review ("CBMR") CBMR On December 17, 2014, the PTAB CBMR On April 2, 2015, the District Court lifted the stay and required the parties to file a joint docket control order. On April 6, 2015, the Court set a Markman Hearing for June 29, 2015, and jury selection for December 14, 2015. On April 15, 2015, the parties filed their joint docket control order. The Court entered its docket control order on April 23, 2015. Due to an apparent scheduling conflict, the Court rescheduled the Markman Hearing to July 8, 2015. On April 22, 2015, the Company filed its third amended complaint against all defendants. The defendants timely answered on May 11, 2015. Each of the defendants answers included a counterclaim for invalidity of the patents.The Company responded to these invalidity contentions on June 1, 2015. On May 13, 2015, the Company filed a motion for entry of an order focusing patent claims and prior art. That motion requested that the Court narrow the number of claims at issue and the number of prior art references that defendants could use in an attempt to invalidate the Company’s patents. On May 27, 2015, the Court held a hearing on the motion and ordered defendants to reduce the number of references in support of any invalidity contention against the patents. On July 13, 2015 the Court entered an order severing the non-active claims out of the case and consolidating claims regarding those patents into a separate set of cases. These new cases address the claims which were held invalid by the PTAB On June 25, 2015, the Company attended mediation with Yelp in an effort to settle the case. That mediation was recessed to explore settlement options. On July 8, 2015 the Company attended the Markman Hearing in order to construe the claims of the patents. On July 14, 2015, the Court entered its Memorandum Opinion and Order regarding claim construction. In that Order, the Court analyzed eleven claim terms. The Court agreed with Blue Calypso’s proffered construction as to seven terms, chose its own construction as to three terms and agreed with defendants proffered construction as to only one term. The Court also expressly rejected defendants argument that the term “testimonial tag” was indefinite. On July 14, 2015, the Company attended court-ordered mediation with Groupon. The result of that mediation was an impasse. On July 16, 2015, the Company attended court-ordered mediation with IZEA. The parties reached a settlement in principal and are currently negotiating the final terms of the agreement. The potential terms of that settlement are confidential. On July 20, 2015, the Company attended court-ordered mediation with Foursquare. The result of that mediation was an impasse. As part of the Company's settlement with Living Social, the Company's attorney is entitled to additional compensation for the value of certain non-monetary arrangements. As of June 30, 2015, the payment of such compensation is not probable or measurable. In the normal course of business, the Company may be involved in legal proceedings, claims and assessments arising in the ordinary course of business. Such matters are subject to many uncertainties, and outcomes are not predictable with assurance. Legal fees for such matters are expensed as incurred and we accrue for adverse outcomes as they become probable and estimable.	NOTE 11 – COMMITMENTS AND CONTINGENCIES Operating leases The Company leases corporate office space under month to month operating leases with no minimum future rental payments. The operating leases do not involve contingent liabilities. On October 1, 2012, the Company entered into a lease agreement for office space for its wholly owned subsidiary in Costa Rica and expiring on September 30, 2015 and will automatically extend for an additional 3 year term unless notification is given three months in advance. Lease payments are $1,345 per month, increasing 3.5% at each anniversary. In connection therewith, the Company paid a security deposit of $1,345. On December 15, 2014, the Company entered into a lease agreement for additional office space for its wholly owned subsidiary in Costa Rica which expires on December 15, 2017 and will automatically extend for an additional 3 year term unless notification is given three months in advance. Lease payments are $1,235 per month, increasing 3.5% at each anniversary. In connection therewith, the Company paid a security deposit of $1,235. Future minimum lease payments under these two agreements are as follows: Year Ending December 31, 2015 $ 28,255 2016 15,355 2017 15,208 Total $ 58,818 Rental expense under the operating leases totaled $51,114 and $36,857 for the years ended December 31, 2014 and 2013, respectively. Litigation On July 31, 2012, the Company filed suit against Groupon, Inc. (“Groupon”) in the Eastern District of Texas in Civil Action, alleging infringement on certain Patents. Between July 19, 2013 and October 3, 2013, Groupon filed petitions with the Patent Trial & Appeals Board (“PTAB”) requesting institution of Covered Business Method Review of all asserted claims. On December 19, 2013 and January 17, 2014, the PTAB issued decisions instituting review on all but four of the asserted claims. On January 14, 2014, the Company and all defendants filed a joint motion to stay the district court litigation. The Court granted the motion and stayed the case on January 16, 2014 pending a decision by the PTAB. Oral Hearings on the Covered Business Method Reviews at the PTAB occurred on September 5, 2014. On February 3, 2014, Groupon filed a petition to the U.S. Court of Appeals for the Federal Circuit for mandamus on the district court's denial of its motion to transfer. On April 23, 2014, the Federal Circuit denied Groupon, Inc.’s bid to transfer our suit from Texas to Illinois, finding that the lower court judge correctly denied Groupon, Inc.’s earlier transfer request. On December 17, 2014, the Patent Trial and Appeal Board issued final decisions in Covered Business Method Review proceedings CBM2013-00035, CBM2013-00033, CBM2013-00046 and CBM2013-00044. In each case, certain claims of each patent were held to be invalid for various reasons. With respect to the ‘516, ‘679, ‘055 and ‘646 patents, many of the claims survived and the patents remain enforceable. All of the claims of the ‘670 patent were held invalid. The Company has appealed each of the final decisions to the United States Federal Circuit Court of Appeals. A decision on those appeals is expected sometime in early 2016. On July 25, 2013, the Company entered into a Settlement Agreement and a License Agreement with MyLikes, Inc. to resolve the patent litigation that was pending in the U.S. District Court for the Eastern District of Texas, Tyler Division ( Blue Calypso, Inc. v. MyLikes Inc. Case Nos. 6:12-CV-838, 6:13-cv-00376, 6:13-cv-00428 and 6:13-cv-00457 ). Pursuant to the Settlement Agreement and License Agreement, MyLikes has agreed to pay the Company the equivalent of a 3.5% royalty for use of the Company’s patents. On August 16, 2013, the Company dismissed its patent infringement action against Living Social, Inc. (Civil Action No. 2:12cv518-JRG United States District Court for the Eastern District of Texas) pursuant to the terms of an otherwise confidential settlement and license agreement. As part of the Company's settlement with Living Social, the Company's attorney is entitled to additional compensation for the value of certain non-monetary arrangements. As of December 31, 2014, the payment of such compensation is not probable or measurable. In the normal course of business the Company may be involved in legal proceedings, claims and assessments arising in the ordinary course of business. Such matters are subject to many uncertainties, and outcomes are not predictable with assurance. Legal fees for such matters are expensed as incurred and we accrue for adverse outcomes as they become probable and estimable.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	NOTE 12 – INCOME TAXES The tax effects of temporary differences that give rise to deferred tax assets are presented below: For The Years Ended December 31, 2014 2013 Deferred Tax Assets: Net operating loss carryforward $ 4,447,768 $ 3,327,518 Stock-based compensation 2,205,340 1,862,399 Total deferred tax assets 6,653,108 5,189,917 Valuation allowance (6,653,108) (5,189,917) Deferred tax asset, net of valuation allowance $ - $ - Changes in valuation allowance $ 1,463,191 $ 2,246,450 The income tax provision (benefit) consists of the following: For The Years Ended December 31, 2014 2013 Federal: Current $ - $ - Deferred (1,463,191) (2,246,450) State and local: Current - - Deferred - - Current Income Tax Expense (Benefit), Total (1,463,191) (2,246,450) Change in valuation allowance 1,463,191 2,246,450 Income tax provision (benefit) $ - $ - A reconciliation of the statutory federal income tax rate to the Company’s effective tax rate is as follows: For The Years Ended December 31, 2014 2013 Tax benefit at federal statutory rate (34.0) % (34.0) % Other non-deductible compensation subject to SEC 162(M) 10.1 % 0 % Permanent differences 5.0 % 1.1 % Change in valuation allowance 18.9 % 32.9 % Effective income tax rate 0 % 0 % The Company assesses the likelihood that deferred tax assets will be realized. To the extent that realization is not likely, a valuation allowance is established. Based upon the Company’s history of losses since inception, management believes that it is more likely than not that future benefits of deferred tax assets will not be realized. At December 31, 2014 and 2013, the Company had $13,081,670 and $9,533,943, respectively, of federal net operating losses that may be available to offset future taxable income. The net operating loss carry forwards, if not utilized, will expire from 2030 to 2034 for federal purposes. In accordance with Section 382 of the Internal Revenue Code, the usage of the Company’s net operating loss carry forwards are subject to annual limitations in the event of a greater than 50% ownership change. The Company files income tax returns in the U.S. federal and Texas jurisdictions and is subject to examination by taxing authorities beginning with the year ended December 31, 2011.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Subsequent Events [Abstract]
Subsequent Events [Text Block]	NOTE 7 – SUBSEQUENT EVENTS On July 20, 2015, the Company issued a senior convertible note with a principal amount of $550,000 (the “July 2015 Note”) for a purchase price of $500,000. The July 2015 Note is due one year from the issuance date. On January 17, 2016, the Company shall be obligated to pay the lender guaranteed the Company's Prepayment Price ”), provided the Company is then and for a period prior thereto in compliance with certain equity conditions and/or (ii) in cash at a 120% premium to the amount then outstanding. If the $550,000 principal amount of the July 2015 Note and all accrued but unpaid interest thereof is not paid in full on or before January 16, 2016, the July 2015 the Company's On August 17, 2015, we entered into a settlement agreement with IZEA, pursuant to which we settled all outstanding litigation with IZEA. Under the Agreement, IZEA has agreed to pay us a royalty fee of 4.125% of revenue from IZEA’s discontinued legacy platforms SocialSpark, Sponsored Tweets and WeReward.	NOTE 13 – SUBSEQUENT EVENTS During March 2015, the remaining shares of the Company’s Series A Convertible Preferred Stock were converted into an aggregate of 47,646 shares of common stock .

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Accounting Policies [Abstract]
Consolidation, Policy [Policy Text Block]	Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.	Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.
Revenue Recognition, Policy [Policy Text Block]		Revenue Recognition Revenue is recognized when persuasive evidence of an arrangement exists, delivery of the product or service has occurred, all obligations have been performed pursuant to the terms of the agreement, the sales price is fixed or determinable, and collectability is reasonably assured. Revenue includes fees received from customers for advertising and marketing service. Revenue is recognized when services are performed or licenses are granted to customers. Revenue from the licensing of the Company’s intellectual property and settlements reached from legal enforcement of the Company’s patent rights is recognized when the arrangement with the licensee has been signed and the license has been delivered and made effective, provided license fees are fixed or determinable and collectability is reasonably assured. The fair value of licenses achieved by ordinary business negotiations is recognized as revenue. The amount of consideration received upon any settlement or judgment is allocated to each element of the settlement based on the fair value of each element. Elements related to licensing agreements, royalty revenues, net of contingent legal fees, are recognized as revenue in the consolidated statement of operations. Elements that are not related to license agreements and royalty revenue in nature will be reflected as a separate line item within the other income section of the consolidated statements of operations. Elements provided in either settlement agreements or judgments include: the value of a license, legal release, and interest. When settlements or judgments are achieved at discounts to the fair value of a license, the Company allocates the full settlement or judgment, excluding specifically named elements as mentioned above, to the value of the license agreement or royalty revenue under the residual method. Legal release as part of a settlement agreement is recognized as a separate line item in the consolidated statements of operations when value can be allocated to the legal release. When the Company reaches a settlement with a defendant, no value is allocated to the legal release since the existence of a settlement removes legal standing to bring a claim of infringement and without a legal claim, the legal release has no economic value. The element that is applicable to interest income will be recorded as a separate line item in other income. The Company does not assume future performance obligations in its license arrangements. Revenue from licensing and related service fees aggregated $23,798 and $245,981 during the years ended December 31, 2014 and 2013. The Company also has revenue from information technology design and programming consulting services. Revenue is recognized in the periods that satisfactory performance of services is delivered to customers. Revenue is recognized when persuasive evidence of an arrangement exists, delivery of the service has occurred, all obligations have been performed pursuant to the terms of the agreement, the sales price is fixed or determinable, and collectability is reasonably assured. Revenue from consulting services was $736,091 and $95,991 during the years ended December 31, 2014 and 2013.
Cost of Sales, Policy [Policy Text Block]		Cost of Revenue Legal costs directly related to the settlement of intellectual property and patent enforcement litigation are recognized as cost of revenue. Other legal expenses incurred in the normal course of the Company's business are expensed when incurred as selling, general and administrative expenses.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the recoverability and useful lives of long-lived assets, the fair value of the Company’s stock, stock-based compensation, debt discounts and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the recoverability and useful lives of long-lived assets, the fair value of the Company’s stock, stock-based compensation, fair values relating to warrant and other derivative liabilities, debt discounts and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Concentrations of Credit Risk As of June 30, 2015, three customers represented 35%, 27% and 18% of the Company’s accounts receivable. As of December 31, 2014, two customers represented 62% and 20% of the Company’s accounts receivable. During the three months ended June 30, 2015, two customers represented 56% and 20% of total revenue. During the six months ended June 30, 2015, three customers represented 60%, 15% and 11% of total revenue. During the three months ended June 30, 2014, three customers represented 57%, 15% and 12% of total revenue. During the six months ended June 30, 2014, three customers represented 46%, 24% and 14% of total revenue.	Concentrations of Credit Risk The Company’s financial instruments that are exposed to a concentration of credit risk are cash and accounts receivable. As of December 31, 2014, excluding the impact of the allowance for doubtful accounts, two customers represented 62% and 20% of the Company’s accounts receivable. As of December 31, 2013, two customers represented 49% and 24% of the Company’s accounts receivable. During the year ended December 31, 2014, three customers represented approximately 59%, 18% and 10% of total revenue, respectively. During the year ended December 31, 2013, two agreements represented 37% and 29% of total revenue.
Cash and Cash Equivalents, Policy [Policy Text Block]		Cash Cash consist of cash held in bank demand deposits. The Company considers all highly liquid instruments with original maturities of three months or less to be cash equivalents. The Company maintains cash in bank accounts located in the United States, which, at times, may exceed federally insured limits or be uninsured. The Company has not experienced any losses in such accounts.
Receivables, Policy [Policy Text Block]		Accounts Receivable Accounts receivable primarily consists of trade receivables, net of allowances. On a periodic basis, the Company evaluates its trade receivables and establishes an allowance for doubtful accounts based on its history of past bad debt expense, collections and current credit conditions. The Company performs on-going credit evaluations of its customers and the customer’s current credit worthiness. Collections and payments from customers are continuously monitored. The Company maintains an allowance for doubtful accounts, which is based upon historical experience as well as specific customer collection issues that have been identified. As of December 31, 2014 and 2013, the Company’s allowance for doubtful accounts was $23,511 and $0, respectively. If the financial condition of customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required in future periods.
Property, Plant and Equipment, Policy [Policy Text Block]		Property and Equipment Property and equipment consists of office equipment and is recorded at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets, which for office equipment is three to five years. Expenditures for major renewals and betterments that extend the useful lives of the property and equipment are capitalized. Expenditures for maintenance and repairs are charged to expense as incurred.
Intangible Assets, Finite-Lived, Policy [Policy Text Block]		Intangible Assets The Company capitalizes certain software development costs as well as purchased software upon achieving technological feasibility of the related products. Software development costs incurred and software purchased prior to achieving technological feasibility are charged to engineering and product development expense as incurred. Commencing upon initial product release, capitalized costs are amortized to cost of software licenses using the straight-line method over the estimated life of the product (which approximates the ratio that current gross revenues for a product bear to the total of current and anticipated future gross revenues for that product), which is generally up to five years.
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]		Impairment of Long-lived Assets The Company reviews the carrying value of intangibles and other long-lived assets for impairment at least annually or whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of long-lived assets is measured by comparing the carrying amount of the asset or asset group to the undiscounted cash flows that the asset or asset group is expected to generate. If the undiscounted cash flows of such assets are less than the carrying amount, the impairment to be recognized is measured by the amount by which the carrying amount of the property, if any, exceeds its fair market value. No impairment was deemed to exist as of December 31, 2014 and 2013. The Company re-evaluates the carrying amounts of its amortizable intangibles at least quarterly to identify any triggering events. As described above, if triggering events require us to undertake an impairment review, it is not possible at this time to determine whether it would be necessary to record a charge or if such charge would be material.
Income Tax, Policy [Policy Text Block]		Income Taxes The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of items that have been included or excluded in the financial statements or tax returns. Deferred tax assets and liabilities are determined on the basis of the difference between the tax basis of assets and liabilities and their respective financial reporting amounts (“temporary differences”) at enacted tax rates in effect for the years in which the temporary differences are expected to reverse. The Company adopted the provisions of Accounting Standards Codification (“ASC”) Topic 740-10, which prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. Management has evaluated and concluded that there were no material uncertain tax positions requiring recognition in the Company’s consolidated financial statements as of December 31, 2014 and 2013. The Company does not expect any significant changes in its unrecognized tax benefits within twelve months of the reporting date. The Company’s policy is to classify assessments, if any, for tax related interest as interest expense and penalties as general and administrative expenses in the consolidated statements of operations.
Earnings Per Share, Policy [Policy Text Block]	Net Loss per Share The Company computes basic net loss per share by dividing net loss per share available to common stockholders by the weighted average number of common shares outstanding for the period, adjusted to give effect to the 50-for-1 reverse stock split, which was effective in the market on July 2, 2015 (see Note 4), and excludes the effects of any potentially dilutive securities. Diluted earnings per share, if presented, would include the dilution that would occur upon the exercise or conversion of all potentially dilutive securities into common stock using the “treasury stock” and/or “if converted” methods as applicable. The computation of basic and diluted loss per share for the three and six months ended June 30, 2015 and 2014 excludes potentially dilutive securities when their inclusion would be anti-dilutive, or if their exercise prices were greater than the average market price of the common stock during the period. Potentially dilutive securities excluded from the computation of basic and diluted net loss per share are as follows: June 30, 2015 June 30, 2014 Convertible notes payable - 60,000 Series A convertible preferred stock - 220,913 Options to purchase common stock 565,939 517,406 Warrants to purchase common stock 220,913 240,092 Restricted stock units - 88,843 Totals 786,852 1,127,254	Net Loss per Share The Company computes basic net income (loss) per share by dividing net income (loss) per share available to common stockholders by the weighted average number of common shares outstanding for the period and excludes the effects of any potentially dilutive securities. Diluted earnings per share, if presented, would include the dilution that would occur upon the exercise or conversion of all potentially dilutive securities into common stock using the “treasury stock” and/or “if converted” methods as applicable. The computation of basic and diluted loss per share as of December 31, 2014 and 2013 excludes potentially dilutive securities when their inclusion would be anti-dilutive, or if their exercise prices were greater than the average market price of the common stock during the period. Potentially dilutive securities excluded from the computation of basic and diluted net income (loss) per share are as follows: December 31, 2014 December 31, 2013 Convertible notes payable - 60,000 Series A convertible preferred stock 47,666 220,913 Options to purchase common stock 441,055 277,551 Warrants to purchase common stock 220,913 649,915 Restricted stock units 43,619 269,133 Totals 753,253 1,477,512
Stockholders' Equity Note, Redeemable Preferred Stock, Issue, Policy [Policy Text Block]		Preferred Stock Preferred shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. The Company classifies conditionally redeemable preferred shares, which includes preferred shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control, as temporary equity. At all other times, the Company classifies its preferred shares in stockholders’ equity. As of December 31, 2014 and 2013, the Company does not have any preferred shares subject to mandatory or conditional redemption outstanding.
Convertible Instrument Policy [Text Block]		Convertible Instruments GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional, as that term is described under applicable GAAP. When the Company has determined that the embedded conversion options should not be bifurcated from their host instruments, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption. The Company also records, when necessary, deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the transaction and the effective conversion price embedded in the preferred shares.
Common Stock Purchase Warrants And Other Derivative Financial Instrument Policy [Text Block]		Common Stock Purchase Warrants and Other Derivative Financial Instruments The Company classifies as equity any contracts that (i) require physical settlement or net-share settlement or (ii) provide the Company with a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement) providing that such contracts are indexed to the Company's own stock. The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the Company’s control) or (ii) gives the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). The Company assesses classification of its common stock purchase warrants and other free standing derivatives at each reporting date to determine whether a change in classification between equity and liabilities is required. The Company’s free-standing derivatives consisted of warrants to purchase common stock that were issued in connection with its private placement transactions (see Note 4) and embedded conversion options with convertible notes. The Company evaluated these derivatives to assess their proper classification in the consolidated balance sheets using the applicable classification criteria enumerated under GAAP. The Company determined that certain common stock purchase warrants and the embedded conversion features do not contain fixed settlement provisions. The exercise price of such warrants is subject to adjustment in the event that the Company subsequently issues equity securities or equity linked securities with exercise prices lower than the exercise price in these warrants. The convertible notes contained a conversion feature such that the Company could not ensure it would have adequate authorized shares to meet all possible conversion demands. As such, the Company was required to record the warrants and debt derivatives which do not have fixed settlement provisions as liabilities and mark to market all such derivatives to fair value at the end of each reporting period. The Company has adopted a sequencing policy that reclassifies contracts (from equity to assets or liabilities) with the most recent inception date first. Thus any available shares are allocated first to contracts with the most recent inception dates.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]		Stock-Based Compensation The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. For employees and directors, the fair value of the award is measured on the grant date and for non-employees, the fair value of the award is generally re-measured on vesting dates and interim financial reporting dates until the service period is complete. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. Stock-based compensation expense is recorded by the Company in the same expense classifications in the consolidated statements of operations, as if such amounts were paid in cash.
Advertising Costs, Policy [Policy Text Block]		Advertising The Company's advertising costs are expensed as incurred. Advertising expense was $2,280 and $13,589 for the years ended December 31, 2014 and 2013.
Accrued Expenses Policy [Text Block]		Accrued expenses: Accrued expenses were comprised of the following: December 31, 2014 December 31, 2013 Payroll $ 169,965 $ 4,878 Legal and accounting services 39,103 - Interest and other 27,458 - Accrued expenses $ 236,526 $ 4,878
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements In April 2015, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) Number 2015-3 entitled “Simplifying the Presentation of Debt Issuance Costs.” The new guidance specifies that debt issuance costs under the new standard are to be netted against the carrying value of the financial liability. Under current guidance, debt issuance costs are recognized as a deferred charge and reported as a separate asset on the balance sheet. The new guidance aligns the treatment of debt issuance costs and debt discounts in that both reduce the carrying value of the liability. It is important to note that neither the recognition nor measurement of debt issuance costs is changed as a result of the ASU. Amortization of debt issuance costs is to be recorded as interest expense on the income statement. The effective date of the new guidance is for fiscal years beginning after December 15, 2015, for public business entities and interim periods within those fiscal years. Early adoption is permitted for financial statements that have not been issued previously. The Company does not believe the effect of the adoption of this standard will have a material impact on the Company’s condensed consolidated financial statements. There are other various updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to have a material impact on the Company's financial position, results of operations or cash flows.	Recent Accounting Pronouncements The FASB has issued ASU No. 2014-12, Compensation – Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period . This ASU requires that a performance target that affects vesting, and that could be achieved after the requisite service period, be treated as a performance condition. As such, the performance target should not be reflected in estimating the grant date fair value of the award. This update further clarifies that compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the period(s) for which the requisite service has already been rendered. The amendments in this ASU are effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. Earlier adoption is permitted. The Company has not yet determined the effect of the adoption of this standard and it is expected to have a material impact on the Company ’ s consolidated financial statements. The FASB has issued ASU No. 2014-09, Revenue from Contracts with Customers . This ASU supercedes the revenue recognition requirements in Accounting Standards Codification 605 - Revenue Recognition and most industry-specific guidance throughout the Codification. The standard requires that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. This ASU is effective on January 1, 2017 and should be applied retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying the ASU recognized at the date of initial application. The Company has not yet determined the effect of the adoption of this standard and it is expected to have an immaterial impact on the Company ’ s consolidated financial statements. In August, 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements – Going Concern (Subtopic 205-40): Disclosure of Uncertainties About an Entities Ability to Continue as a Going Concern. The standard is intended to define management’s responsibility to decide whether there is substantial doubt about an organization’s ability to continue as a going concern and to provide related footnote disclosures. The standard requires management to decide whether there are conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued. The standard provides guidance to an organization’s management, with principles and definitions that are intended to reduce diversity in the timing and content of disclosures that are commonly provided by organizations in the footnotes. The standard becomes effective in the annual period ending after December 15, 2016, with early application permitted. The adoption of this pronouncement is not expected to have a material impact on the consolidated financial statements. Management’s evaluations regarding the events and conditions that raise substantial doubt regarding the Company’s ability to continue as a going concern have been disclosed in Note 2. There are other various updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on the Company's financial position, results of operations or cash flows.
Subsequent Events, Policy [Policy Text Block]	Subsequent Events The Company evaluates events that have occurred after the balance sheet date but before the financial statements are issued. Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the condensed consolidated financial statements, except as disclosed.	Subsequent Events The Company evaluates events that have occurred after the balance sheet date but before the financial statements are issued. Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the consolidated financial statements, except as disclosed.
Deferred Charges, Policy [Policy Text Block]	Deferred Offering Costs The Company classifies amounts related to a potential future offering not closed as of the balance sheet date as Deferred Offering Costs. During the six months ended June 30, 2015, the Company capitalized costs in the amount of $79,912 as Deferred Offering Costs in the accompanying condensed consolidated balance sheet.

SUMMARY OF SIGNIFICANT ACCOUN23

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Accounting Policies [Abstract]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	June 30, 2015 June 30, 2014 Convertible notes payable - 60,000 Series A convertible preferred stock - 220,913 Options to purchase common stock 565,939 517,406 Warrants to purchase common stock 220,913 240,092 Restricted stock units - 88,843 Totals 786,852 1,127,254	December 31, 2014 December 31, 2013 Convertible notes payable - 60,000 Series A convertible preferred stock 47,666 220,913 Options to purchase common stock 441,055 277,551 Warrants to purchase common stock 220,913 649,915 Restricted stock units 43,619 269,133 Totals 753,253 1,477,512
Schedule of Accrued Liabilities [Table Text Block]		December 31, 2014 December 31, 2013 Payroll $ 169,965 $ 4,878 Legal and accounting services 39,103 - Interest and other 27,458 - Accrued expenses $ 236,526 $ 4,878

FAIR VALUE OF FINANCIAL INSTR24

FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)	12 Months Ended
	Dec. 31, 2014
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	December 31, Quoted Prices Significant Significant Derivative liabilities $ 2,030 $ - $ - $ 2,030
Schedule of Warrants and Conversion Options, Valuation Assumptions [Table Text Block]	December 31, 2014 December 31 , 2013 Dividend Yield 0.00% 0.00% Volatility 78.94% 80.34% to 85.43% Risk-free Interest Rate 0.07% 0.10% -1.71% Term 0.66 – 0.68 years 0.90 – 3.5 years
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	Balance-January 1, 2013 $ 10,964,006 Aggregate fair value of derivative instruments issued 3,053,272 Transfers out due to the expiration and modification of derivative aspect of financial instrument (6,384,814) Change in fair value of derivative liabilities (7,630,434) Balance – December 31, 2013 2,030 Change in fair value of derivative liabilities (2,030) Balance – December 31, 2014 $ -

PROPERTY AND EQUIPMENT (Tables)

PROPERTY AND EQUIPMENT (Tables)	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]	December 31, 2014 December 31, 2013 Office Equipment $ 24,961 $ 23,781 Less: Accumulated depreciation (18,646) (13,772) Property and equipment, net $ 6,315 $ 10,009

INTANGIBLE ASSETS (Tables)

INTANGIBLE ASSETS (Tables)	12 Months Ended
	Dec. 31, 2014
Disclosure Text Block [Abstract]
Schedule of Finite-Lived Intangible Assets [Table Text Block]	December 31, 2014 December 31, 2013 Capitalized Software Development Costs $ 1,781,053 $ 1,631,921 Less: Accumulated amortization (986,502) (647,247) Net capitalized development costs $ 794,551 $ 984,674
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	2015 $ 333,974 2016 242,323 2017 130,656 2018 69,694 Thereafter 17,904 Total $ 794,551

STOCKHOLDERS' EQUITY (Tables)

STOCKHOLDERS' EQUITY (Tables)	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Stockholders' Equity Note [Abstract]
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	June 30, 2015 June 30, 2014 Risk-free interest rate 1.68% - 2.07% 2.13% - 2.73% Dividend yield 0% 0% Stock price volatility 123.45%-145.24% 77.6% - 79.2% Expected life 5 - 10 years 8-10 years Weighted average grant date fair value $5.98 $5.50	December 31, 2014 December 31, 2013 Risk-free interest rate 1.97%-2.73% 0.62%-0.86% Dividend yield 0% 0% Stock price volatility 76%-79% 35%-118% Expected life 6-10 years 6-10 years Weighted average grant date fair value $5.50 $5.50
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	Weighted Remaining Contractual Term Weighted-Average Exercise Price Aggregate Intrinsic Value Shares Outstanding at January 1, 2015 441,064 $ 8.44 4.2 $ 858,766 Granted 126,500 $ 6.88 10.0 Canceled/expired (1,625) $ 5.73 Outstanding at June 30, 2015 565,939 $ 8.09 4.9 $ 118,486 Exercisable at June 30, 2015 344,683 $ 8.05 3.7 $ 110,570	Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term Aggregate Intrinsic Value Shares Outstanding at January 1, 2013 189,211 $ 12.540 9.35 $ - Grants 113,171 $ 11.585 10.00 $ - Exercised - Forfeitures or expirations (24,830) $ 41.500 Outstanding at January 1, 2014 277,552 $ 9.570 8.7 $ 259,558 Grants 246,255 $ 6.500 10.00 $ - Exercised (8,400) Forfeitures or expirations (74,352) 8.115 Outstanding at December 31, 2014 441,055 $ 8.435 4.2 $ 858,766 Exercisable at December 31, 2014 227,263 $ 8.110 4.3 $ 573,899
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]	Options Outstanding Options Exercisable Weighted Average Remaining Life In Years Exercisable Number of Options Exercise Price Number of Options $ 0.00-5.00 165,081 4.0 149,247 5.01-12.50 375,449 5.3 174,494 12.51-25.00 15,008 4.7 15,008 25.01-45.00 10,401 4.7 5,934 565,939 4.9 344,683	Options Outstanding Options Exercisable Weighted Average Remaining Life In Years Exercisable Number of Options Exercise Price Number of Options $ 0.00-5.00 157,581 4.6 138,831 5.50-12.50 258,074 3.7 67,499 13.00-25.00 15,000 7.4 15,000 25.50-45.00 10,400 5.2 5,933 441,055 4.1 227,263
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]		Restricted shares issued as of January 1, 2013 269,133 Granted - Total Restricted Shares Issued at December 31, 2013 269,133 Granted - Total Restricted Shares Issued at December 31, 2014 269,133 Vested at December 31, 2014 (225,514) Unvested restricted shares as of December 31, 2014 43,619
Schedule Of Outstanding Warrants [TableTextBlock]		Exercise Price Number Outstanding Expiration Date $ 5.00 220,913 August 2016 .
Schedule Of Warrants Activity [TableTextBlock]	Weighted-Average Remaining Contractual Term Aggregate Intrinsic Value Weighted-Average Exercise Price Shares Outstanding at January 1, 2015 220,913 $ 5.00 1.7 $ 1,325,478 Grants - $ - Exercised - Forfeitures or expirations - Outstanding at June 30, 2015 220,913 $ 5.00 1.2 $ 110,457 Exercisable at June 30, 2015 220,913 $ 5.00 1.2 $ 110,457	Weighted-Average Remaining Contractual Term Aggregate Intrinsic Value Weighted-Average Exercise Price Shares Outstanding at January 1, 2013 649,915 $ 3.85 4.4 $ - Issued - Exercised - Forfeitures or expirations - Outstanding at January 1, 2014 649,915 $ 3.85 3.4 $ - Grants - $ - Exercised (409,823) $ 2.50 Forfeitures or expirations (19,179) $ 31.00 Outstanding at December 31, 2014 220,913 $ 2.50 1.7 $ 1,325,478 Exercisable at December 31, 2014 220,913 $ 2.50 1.7 $ 1,325,478

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	Year Ending December 31, 2015 $ 28,255 2016 15,355 2017 15,208 Total $ 58,818

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	For The Years Ended December 31, 2014 2013 Deferred Tax Assets: Net operating loss carryforward $ 4,447,768 $ 3,327,518 Stock-based compensation 2,205,340 1,862,399 Total deferred tax assets 6,653,108 5,189,917 Valuation allowance (6,653,108) (5,189,917) Deferred tax asset, net of valuation allowance $ - $ - Changes in valuation allowance $ 1,463,191 $ 2,246,450
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	For The Years Ended December 31, 2014 2013 Federal: Current $ - $ - Deferred (1,463,191) (2,246,450) State and local: Current - - Deferred - - Current Income Tax Expense (Benefit), Total (1,463,191) (2,246,450) Change in valuation allowance 1,463,191 2,246,450 Income tax provision (benefit) $ - $ -
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	For The Years Ended December 31, 2014 2013 Tax benefit at federal statutory rate (34.0) % (34.0) % Other non-deductible compensation subject to SEC 162(M) 10.1 % 0 % Permanent differences 5.0 % 1.1 % Change in valuation allowance 18.9 % 32.9 % Effective income tax rate 0 % 0 %

REVERSE STOCK SPLIT (Details)

REVERSE STOCK SPLIT (Details) - $ / shares	Jul. 02, 2015	Mar. 12, 2015	Nov. 09, 2012	Jun. 30, 2015	Dec. 31, 2014	Dec. 31, 2013
REVERSE STOCK SPLIT (Details) [Line Items]
Stockholders' Equity, Reverse Stock Split	Effective June 26, 2015 at the state level and July 2, 2015 in the market, the Company filed an amendment to its Articles of Incorporation and effected a 50-for-1 reverse stock split of its issued and outstanding shares of common stock, $0.0001 par value
Common Stock, Par or Stated Value Per Share (in Dollars per share)				$ 0.0001	$ 0.0001	$ 0.0001
Conversion of Stock, Shares Issued			74,669
Subsequent Event [Member]
REVERSE STOCK SPLIT (Details) [Line Items]
Stockholders' Equity, Reverse Stock Split	Effective in the market on July 2, 2015, the Company filed an amendment to its Articles of Incorporation and effected a 50-for-1 reverse stock split of its issued and outstanding shares of common stock, $0.0001 par value
Common Stock, Par or Stated Value Per Share (in Dollars per share)	$ 0.0001
Conversion of Stock, Shares Converted	250,666,631
Conversion of Stock, Shares Issued	5,013,366	47,646

GOING CONCERN AND MANAGEMENT'31

GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS (Details) - USD ($)	Jul. 20, 2015	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014	Dec. 31, 2013
GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS (Details) [Line Items]
Cash		$ 74,725		$ 1,103,201
Working Capital		(12,912)		1,058,727
Net Cash Provided by (Used in) Operating Activities		$ (791,443)	$ (1,249,977)	(2,367,655)	$ (2,756,901)
Proceeds from Issuance of Common Stock				1,330,000	$ 1,501,000
Proceeds from Stock Options Exercised			$ 21,728	21,728
Subsequent Event [Member]
GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS (Details) [Line Items]
Convertible Debt, Noncurrent	$ 550,000
Proceeds from Convertible Debt	$ 500,000
Common Stock [Member]
GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS (Details) [Line Items]
Proceeds from Issuance of Common Stock				1,330,000
Proceeds from Stock Options Exercised				$ 1,046,286

SUMMARY OF SIGNIFICANT ACCOUN32

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014	Dec. 31, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]
Licenses Revenue (in Dollars)					$ 23,798	$ 245,981
Sales Revenue, Services, Other (in Dollars)					736,091	95,991
Allowance for Doubtful Accounts Receivable (in Dollars)					$ 23,511	$ 0
Finite-Lived Intangible Asset, Useful Life					5 years	5 years
Advertising Expense (in Dollars)					$ 2,280	$ 13,589
Deferred Offering Costs (in Dollars)	$ 79,912		$ 79,912
Customer 1 [Member] | Accounts Receivable [Member]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]
Concentration Risk, Percentage			35.00%		62.00%	49.00%
Customer 1 [Member] | Sales [Member]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]
Concentration Risk, Percentage	56.00%	57.00%	60.00%	46.00%	59.00%	37.00%
Customer 2 [Member] | Accounts Receivable [Member]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]
Concentration Risk, Percentage			27.00%		20.00%	24.00%
Customer 2 [Member] | Sales [Member]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]
Concentration Risk, Percentage	20.00%	15.00%	15.00%	24.00%	18.00%	29.00%
Customer 3 [Member] | Accounts Receivable [Member]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]
Concentration Risk, Percentage			18.00%
Customer 3 [Member] | Sales [Member]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]
Concentration Risk, Percentage		12.00%	11.00%	14.00%	10.00%
Minimum [Member] | Office Equipment [Member]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]
Property, Plant and Equipment, Useful Life					3 years
Maximum [Member] | Office Equipment [Member]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]
Property, Plant and Equipment, Useful Life					5 years

SUMMARY OF SIGNIFICANT ACCOUN33

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Potentially dilutive securities excluded from the computation of basic and diluted net income (loss) per share - shares	6 Months Ended		12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014	Dec. 31, 2013
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities excluded from the computation of basic and diluted net income (loss) per share	786,852	1,127,254	753,253	1,477,512
Equity Option [Member] | Common Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities excluded from the computation of basic and diluted net income (loss) per share			441,055	277,551
Warrant [Member] | Common Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities excluded from the computation of basic and diluted net income (loss) per share			220,913	649,915
Restricted Stock Units (RSUs) [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities excluded from the computation of basic and diluted net income (loss) per share		88,843	43,619	269,133
Series A Preferred Stock [Member] | Convertible Debt Securities [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities excluded from the computation of basic and diluted net income (loss) per share		220,913	47,666	220,913
Convertible Notes Payable [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities excluded from the computation of basic and diluted net income (loss) per share		60,000		60,000

SUMMARY OF SIGNIFICANT ACCOUN34

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Accrued expenses - USD ($)	Jun. 30, 2015	Dec. 31, 2014	Dec. 31, 2013
Accrued expenses [Abstract]
Payroll		$ 169,965	$ 4,878
Legal and accounting services		39,103
Interest and other		27,458
Accrued expenses	$ 107,040	$ 236,526	$ 4,878

FAIR VALUE OF FINANCIAL INSTR35

FAIR VALUE OF FINANCIAL INSTRUMENTS (Details)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Fair Value Disclosures [Abstract]
Fair Value Assumptions, Expected Dividend Rate	0.00%	0.00%

FAIR VALUE OF FINANCIAL INSTR36

FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - Financial liabilities measured at fair value on a recurring basis	Dec. 31, 2014USD ($)
FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - Financial liabilities measured at fair value on a recurring basis [Line Items]
Derivative liabilities	$ 2,030
Fair Value, Inputs, Level 1 [Member]
FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - Financial liabilities measured at fair value on a recurring basis [Line Items]
Derivative liabilities
Fair Value, Inputs, Level 2 [Member]
FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - Financial liabilities measured at fair value on a recurring basis [Line Items]
Derivative liabilities
Fair Value, Inputs, Level 3 [Member]
FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - Financial liabilities measured at fair value on a recurring basis [Line Items]
Derivative liabilities	$ 2,030

FAIR VALUE OF FINANCIAL INSTR37

FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - The fair value of the warrants and the conversion options	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - The fair value of the warrants and the conversion options [Line Items]
Dividend Yield	0.00%	0.00%
Volatility	78.94%
Risk-free Interest Rate	0.07%
Minimum [Member]
FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - The fair value of the warrants and the conversion options [Line Items]
Volatility		80.34%
Risk-free Interest Rate		0.10%
Term	240 days	328 days
Maximum [Member]
FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - The fair value of the warrants and the conversion options [Line Items]
Volatility		85.43%
Risk-free Interest Rate		1.71%
Term	248 days	3 years 6 months

FAIR VALUE OF FINANCIAL INSTR38

FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - Summary of the changes in the fair value - USD ($)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Summary of the changes in the fair value [Abstract]
Balance-January 1, 2013	$ 2,030	$ 10,964,006
Balance		2,030
Aggregate fair value of derivative instruments issued		3,053,272
Transfers out due to the expiration and modification of derivative aspect of financial instrument		(6,384,814)
Change in fair value of derivative liabilities	$ (2,030)	$ (7,630,434)

PROPERTY AND EQUIPMENT (Details

PROPERTY AND EQUIPMENT (Details) - USD ($)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Property, Plant and Equipment [Abstract]
Depreciation	$ 4,874	$ 6,619

PROPERTY AND EQUIPMENT (Detai40

PROPERTY AND EQUIPMENT (Details) - Property and equipment - USD ($)	Jun. 30, 2015	Dec. 31, 2014	Dec. 31, 2013
Property and equipment [Abstract]
Office Equipment		$ 24,961	$ 23,781
Less: Accumulated depreciation		(18,646)	(13,772)
Property and equipment, net	$ 10,022	$ 6,315	$ 10,009

INTANGIBLE ASSETS (Details)

INTANGIBLE ASSETS (Details) - USD ($)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Disclosure Text Block [Abstract]
Stock Issued During Period, Shares, Acquisitions (in Shares)		1,000,000
Stock Issued During Period, Value, Acquisitions		$ 150,000
Finite-Lived Intangible Asset, Useful Life	5 years	5 years
Amortization of Intangible Assets	$ 339,255	$ 294,290
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	4 years

INTANGIBLE ASSETS (Details) - I

INTANGIBLE ASSETS (Details) - Intangible assets components - USD ($)	Jun. 30, 2015	Dec. 31, 2014	Dec. 31, 2013
Intangible assets components [Abstract]
Capitalized Software Development Costs		$ 1,781,053	$ 1,631,921
Less: Accumulated amortization	$ (1,156,478)	(986,502)	(647,247)
Net capitalized development costs	$ 775,190	$ 794,551	$ 984,674

INTANGIBLE ASSETS (Details) - T

INTANGIBLE ASSETS (Details) - The capitalized development costs amortization	Dec. 31, 2014USD ($)
The capitalized development costs amortization [Abstract]
2,015	$ 333,974
2,016	242,323
2,017	130,656
2,018	69,694
Thereafter	17,904
Total	$ 794,551

NOTES PAYABLE (Details)

NOTES PAYABLE (Details)	Nov. 10, 2014USD ($)$ / sharesshares	May. 06, 2013USD ($)$ / sharesshares	Feb. 12, 2013USD ($)$ / sharesshares	Jan. 15, 2013USD ($)	Nov. 15, 2012USD ($)$ / shares$ / itemshares	Nov. 09, 2012USD ($)shares	Apr. 12, 2012USD ($)	Dec. 31, 2012USD ($)	Jun. 30, 2015USD ($)	Jun. 30, 2014USD ($)	Dec. 31, 2014USD ($)$ / sharesshares	Dec. 31, 2013USD ($)$ / sharesshares	Sep. 13, 2013$ / shares	May. 31, 2013USD ($)
NOTES PAYABLE (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage						8.00%
Notes Payable, Current						$ 368,059
Accounts Payable, Current									$ 108,139		$ 24,600	$ 161,225
Debt Conversion, Original Debt, Amount						$ 545,958					$ 550,000	2,915,000
Conversion of Stock, Shares Issued (in Shares) | shares						74,669
Debt Instrument, Convertible, Terms of Conversion Feature						The 8% Convertible Note is convertible into shares of the Company's Common Stock at a conversion price equal to the greater of: (i) $7.50 per share or (ii) the price per share at which Common Stock is sold in a subsequent financing. Upon effectiveness of the registration statement covering the resale of such shares, the 8% Convertible Note will automatically convert into shares of the Company's Common Stock at the applicable conversion price. The aggregate grant date fair value of the common stock was applied to the principal amount of the May 2013 Debenture to determine the debt discount
Debt Instrument, Unamortized Discount		$ 229,691
Amortization of Financing Costs												234,500
Debt Instrument, Unamortized Discount (Premium), Net												223,419
Amortization of Debt Discount (Premium)										$ 125,550	$ 223,419	$ 751,126
Repayments of Convertible Debt											50,000
Stock Issued During Period, Value, Issued for Services									$ 128,401		$ 195,468
Senior Secured Convertible Debentures [Member]
NOTES PAYABLE (Details) [Line Items]
Proceeds from Convertible Debt				$ 50,000			$ 515,000
Debt Instrument, Interest Rate, Stated Percentage											8.00%
Debt Instrument, Maturity Date							Jun. 30, 2013
Debt Instrument, Face Amount												$ 515,000
Debt Instrument, Increase, Accrued Interest												$ 30,764
Debt Instrument, Convertible, Number of Equity Instruments												400,000
Cancellation of Unissued Common Stock Shares (in Shares) | shares												257,727
Available-for-sale Debt Securities, Gross Unrealized Loss												$ 5,459,582
Aztec [Member]
NOTES PAYABLE (Details) [Line Items]
Accounts Payable, Current						$ 177,899
May 2013 Debenture [Member]
NOTES PAYABLE (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage		10.00%
Debt Instrument, Face Amount												2,400,000
Debt Instrument, Increase, Accrued Interest												120,000
Debt Instrument, Unamortized Discount														$ 229,691
Amortization of Financing Costs												$ 234,500
Debt Instrument, Convertible, Conversion Price (in Dollars per share) | $ / shares		$ 12.50										$ 6.50	$ 12.50
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | shares		24,000
Debt Conversion Converted Instrument Expiration Period		2 years
Proceeds from Issuance of Debt		$ 2,400,000
Amortization of Debt Discount (Premium)												$ 229,691
Gain (loss) on Debt Modification and Conversion Inducement												$ 1,351,400
Debt Conversion, Converted Instrument, Amount		$ 254,400
Stock Issued During Period, Shares, Conversion of Notes Payable and Accrued Interest (in Shares) | shares												388,000
Debt Instrument, Fee Amount												$ 62,500
Stock Issued During Period, Shares, Issued for Services (in Shares) | shares												20,000
Stock Issued During Period, Value, Issued for Services												$ 172,000
Convertible Note [Member]
NOTES PAYABLE (Details) [Line Items]
Debt Conversion, Original Debt, Amount			$ 550,000
Debt Instrument, Unamortized Discount						$ 341,224
Amortization of Financing Costs												244,705
Debt Instrument, Convertible, Conversion Price (in Dollars per share) | $ / shares			$ 7.50
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | shares			73,733
Purchase Agreement [Member]
NOTES PAYABLE (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage					10.00%
Debt Instrument, Unamortized Discount					$ 225,000
Debt Instrument, Convertible, Conversion Price (in Dollars per share) | $ / shares					$ 10
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | shares					250
Private Offering, Maximum Limit Amount					$ 3,000,000
Private Offering Per Unit Cost (in Dollars per Item) | $ / item					50,000
Debt Conversion Converted Instrument Expiration Period					2 years
Number of Units Sold								9
Proceeds from Issuance of Debt								$ 450,000
Debt Instrument, Increase (Decrease), Other, Net												150,000
Debt Instrument, Unamortized Discount (Premium), Net												268,210
Amortization of Debt Discount (Premium)											$ 223,419	267,272
Long-term Debt, Gross												$ 376,581
November 2012 Debentures [Member]
NOTES PAYABLE (Details) [Line Items]
Debt Instrument, Face Amount	$ 50,000
Debt Instrument, Convertible, Conversion Price (in Dollars per share) | $ / shares	$ 4										$ 3.83
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | shares	550										143,550
Long-term Debt, Gross											$ 550,000
Gain (loss) on Debt Modification and Conversion Inducement											413,917
Repayments of Convertible Debt											$ 50,000
Scenario, Forecast [Member] | May 2013 Debenture [Member]
NOTES PAYABLE (Details) [Line Items]
Debt Instrument, Convertible, Conversion Price (in Dollars per share) | $ / shares													$ 6.50

WARRANT DERIVATIVE LIABILITIES

WARRANT DERIVATIVE LIABILITIES (Details) - USD ($)	Apr. 29, 2013	Apr. 19, 2013	Apr. 12, 2012	Mar. 31, 2012	Jun. 30, 2014	Jun. 30, 2014	Dec. 31, 2014	Dec. 31, 2013	Jun. 30, 2015	Jan. 01, 2015	Sep. 13, 2013
WARRANT DERIVATIVE LIABILITIES (Details) [Line Items]
Class of Warrant or Right, Outstanding (in Shares)	220,913	441,826							220,913	220,913	220,913
Equity, Fair Value Adjustment	$ 2,013,972	$ 4,027,945
Fair Value Adjustment of Warrants	3,041,342
Interest Expense, Debt	$ 1,027,381
Warrants Issued			$ 130,000	$ 58,910
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)			$ 5						$ 5	$ 5	$ 2.50
Derivative, Gain (Loss) on Derivative, Net					$ 487	$ 2,030	$ 2,030	$ 7,630,434
Derivative [Member]
WARRANT DERIVATIVE LIABILITIES (Details) [Line Items]
Equity, Fair Value Adjustment							2,356,869
Derivative, Gain (Loss) on Derivative, Net							$ 64,017

STOCKHOLDERS' EQUITY (Details)

STOCKHOLDERS' EQUITY (Details) - USD ($)	Jul. 02, 2015	Jun. 30, 2015	May. 31, 2015	Apr. 30, 2015	Mar. 03, 2015	Jan. 31, 2015	Jan. 01, 2015	Dec. 31, 2014	Dec. 15, 2014	Dec. 12, 2014	Sep. 26, 2014	Aug. 18, 2014	Apr. 09, 2014	Mar. 14, 2014	Mar. 10, 2014	Jan. 10, 2014	Oct. 15, 2013	Jan. 01, 2013	Nov. 09, 2012	Dec. 31, 2014	Jun. 30, 2014	May. 31, 2014	Apr. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2013	Jan. 09, 2014	Sep. 13, 2013	Apr. 12, 2012
STOCKHOLDERS' EQUITY (Details) [Line Items]
Stock Cancelled During Period, Shares for Services (in Shares)																															331,460
Conversion of Stock, Shares Issued (in Shares)																			74,669
Shares Issued, Price Per Share (in Dollars per share)					$ 3.395
Stock Issued During Period, Value, Issued for Services																										$ 128,401		$ 195,468
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)																										126,500			246,255	113,171
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)		$ 5					$ 5																	$ 5		$ 5							$ 2.50	$ 5
Proceeds from Warrant Exercises																											$ 1,024,558	$ 1,024,558
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term							4 years 73 days											9 years 127 days								4 years 328 days		8 years 255 days	4 years 73 days
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share)																										$ 6.88			$ 6.500	$ 11.585
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price (in Dollars per share)		8.05						$ 8.110												$ 8.110				8.05		$ 8.05		$ 8.110	$ 8.110
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term																										3 years 255 days			4 years 109 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (in Shares)																													8,400
Proceeds from Stock Options Exercised																											21,728	$ 21,728
Share-based Compensation																										$ 168,897	1,109,565	$ 3,731,915			$ 2,530,061
Stockholders' Equity, Reverse Stock Split	Effective June 26, 2015 at the state level and July 2, 2015 in the market, the Company filed an amendment to its Articles of Incorporation and effected a 50-for-1 reverse stock split of its issued and outstanding shares of common stock, $0.0001 par value
Common Stock, Par or Stated Value Per Share (in Dollars per share)		$ 0.0001						$ 0.0001												$ 0.0001				$ 0.0001		$ 0.0001		$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001
Adjustments to Additional Paid in Capital, Other								$ 24,024
Private Placement [Member]
STOCKHOLDERS' EQUITY (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)																	230,923
Sale of Stock, Price Per Share (in Dollars per share)																	$ 6.50
Stock Issued During Period, Value, New Issues																	$ 1,501,000
Series A Convertible Preferred Stock [Member]
STOCKHOLDERS' EQUITY (Details) [Line Items]
Conversion of Stock, Shares Converted (in Shares)					161,827					588,241																					949,932
Conversion of Stock, Shares Issued (in Shares)					47,646
Common Stock [Member]
STOCKHOLDERS' EQUITY (Details) [Line Items]
Conversion of Stock, Shares Converted (in Shares)	250,666,631
Conversion of Stock, Shares Issued (in Shares)	5,013,366									173,267																					279,823
Shares Issued, Price Per Share (in Dollars per share)										$ 3.40																				$ 3.40	$ 3.40
Stock Issued During Period, Shares, New Issues (in Shares)												285,000
Stock Issued During Period, Value, New Issues												$ 1,330,000
Sales Commissions and Fees												$ 95,000
Common Stock, Par or Stated Value Per Share (in Dollars per share)	$ 0.0001
Employee Stock Option [Member]
STOCKHOLDERS' EQUITY (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)																															113,171
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term																															10 years
Share-based Compensation Arrangement By Share-based Payment Award Options, Grant Date, Intrinsic Value																															$ 614,342
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (in Shares)													6,400
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price (in Dollars per share)													$ 3.395
Proceeds from Stock Options Exercised													$ 21,728
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options		$ 747,826						$ 164,541												$ 164,541				$ 747,826		$ 747,826		$ 164,541	$ 164,541
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition																										3 years		2 years
Share-based Compensation																								112,744	$ 157,828	$ 168,897	233,545	$ 1,250,113			551,483
Restricted Stock [Member]
STOCKHOLDERS' EQUITY (Details) [Line Items]
Share-based Compensation																								$ 0	$ 438,010	$ 0	$ 876,020	2,478,124			$ 1,784,014
Warrant Agreement Amendment No 4 [Member]
STOCKHOLDERS' EQUITY (Details) [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																$ 2.50																$ 2.50
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)																224,000
Proceeds from Warrant Exercises																$ 560,000
Gain (Loss) on Derivative Instruments, Net, Pretax																												241,176
Warrant Agreement Amendment No 3 [Member]
STOCKHOLDERS' EQUITY (Details) [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																																$ 2.50
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)															185,823
Proceeds from Warrant Exercises															$ 464,558
Gain (Loss) on Derivative Instruments, Net, Pretax																												$ 219,773
Investor Relations Services [Member]
STOCKHOLDERS' EQUITY (Details) [Line Items]
Stock Issued During Period, Shares, Issued for Services (in Shares)																										8,188		22,154
Stock Issued During Period, Value, Issued for Services																										$ 60,000		$ 130,000
Legal Services [Member]
STOCKHOLDERS' EQUITY (Details) [Line Items]
Stock Issued During Period, Shares, Issued for Services (in Shares)																										11,273		9,046
Stock Issued During Period, Value, Issued for Services																										$ 68,401		$ 65,468
Consultants [Member] | Common Stock [Member]
STOCKHOLDERS' EQUITY (Details) [Line Items]
Stock Cancelled During Period, Shares for Services (in Shares)																															5,000
Stock Issued During Period, Shares, Issued for Services (in Shares)																															23,561
Stock Issued During Period, Value, Issued for Services																															$ 277,039
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)																															28,561
Consultants [Member] | Employee Stock Option [Member]
STOCKHOLDERS' EQUITY (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)		8,000	10,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period																															3 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term		10 years	10 years
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share)		$ 7	$ 7																												$ 12
Share-based Compensation Arrangement By Share-based Payment Award Options, Grant Date, Intrinsic Value		$ 41,688	$ 52,049
Chief Executive Officer [Member]
STOCKHOLDERS' EQUITY (Details) [Line Items]
Stock Cancelled During Period, Shares for Services (in Shares)																												2,222
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)																												2,000
Stock Cancelled During Period, Value for Services																												$ 10,000
Chief Executive Officer [Member] | Common Stock [Member]
STOCKHOLDERS' EQUITY (Details) [Line Items]
Stock Cancelled During Period, Shares for Services (in Shares)											15,000
Stock Issued During Period, Value, New Issues									$ 15,000
Stock Cancelled During Period, Value for Services											$ 85,000
Chief Executive Officer [Member] | Employee Stock Option [Member]
STOCKHOLDERS' EQUITY (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)														184,655
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period														3 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value														$ 800,000
Officers' Compensation														1,140,000
Payments to Employees														85,000
Stock Granted, Value, Share-based Compensation, Gross														$ 1,055,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price (in Dollars per share)														$ 7
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term														10 years
Employees [Member] | Employee Stock Option [Member]
STOCKHOLDERS' EQUITY (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)			1,000																		2,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period			3 years																		3 years										2 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term			10 years
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share)			$ 6.50																		$ 5.50										$ 7
Share-based Compensation Arrangement By Share-based Payment Award Options, Grant Date, Intrinsic Value			$ 5,570
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value																					$ 9,000
Employees And Contractor [Member] | Employee Stock Option [Member]
STOCKHOLDERS' EQUITY (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)																							34,600
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period																							3 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value																							$ 170,000
Director [Member] | Employee Stock Option [Member]
STOCKHOLDERS' EQUITY (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)				80,000																7,500		25,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period																						3 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term				10 years
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share)				$ 7																		$ 5
Share-based Compensation Arrangement By Share-based Payment Award Options, Grant Date, Intrinsic Value				$ 493,774
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value																						$ 101,000
New Director [Member] | Employee Stock Option [Member]
STOCKHOLDERS' EQUITY (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)			20,000			7,500
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period						3 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term			10 years			10 years
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share)			$ 7			$ 5
Share-based Compensation Arrangement By Share-based Payment Award Options, Grant Date, Intrinsic Value			$ 128,115			$ 34,945
Long Term Incentive Plan [Member] | Employee Stock Option [Member]
STOCKHOLDERS' EQUITY (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in Shares)								700,000												700,000								700,000	700,000
Minimum [Member] | Employees And Contractor [Member] | Employee Stock Option [Member]
STOCKHOLDERS' EQUITY (Details) [Line Items]
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share)																							$ 6
Maximum [Member] | Employees And Contractor [Member] | Employee Stock Option [Member]
STOCKHOLDERS' EQUITY (Details) [Line Items]
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share)																							$ 6.50

STOCKHOLDERS' EQUITY (Details)

STOCKHOLDERS' EQUITY (Details) - Assumptions used in determining fair value of employee and vesting non-employee options - $ / shares	6 Months Ended		12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014	Dec. 31, 2013
STOCKHOLDERS' EQUITY (Details) - Assumptions used in determining fair value of employee and vesting non-employee options [Line Items]
Dividend yield	0.00%	0.00%	0.00%	0.00%
Weighted average grant date fair value (in Dollars per share)	$ 5.98	$ 5.50	$ 5.50	$ 5.50
Minimum [Member]
STOCKHOLDERS' EQUITY (Details) - Assumptions used in determining fair value of employee and vesting non-employee options [Line Items]
Risk-free interest rate	1.68%	2.13%	1.97%	0.62%
Stock price volatility	123.45%	77.60%	76.00%	35.00%
Expected life	5 years	8 years	6 years	6 years
Maximum [Member]
STOCKHOLDERS' EQUITY (Details) - Assumptions used in determining fair value of employee and vesting non-employee options [Line Items]
Risk-free interest rate	2.07%	2.73%	2.73%	0.86%
Stock price volatility	145.24%	79.20%	79.00%	118.00%
Expected life	10 years	10 years	10 years	10 years

STOCKHOLDERS' EQUITY (Details48

STOCKHOLDERS' EQUITY (Details) - Stock option activity - USD ($)	Jan. 01, 2015	Jan. 01, 2013	Jun. 30, 2015	Dec. 31, 2014	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2013
Stock option activity [Abstract]
Options, Outstanding, Shares	441,055	189,211	441,055	277,552			189,211
Options Outstanding, Weighted-Average Exercise Price (in Dollars per share)	$ 8.435	$ 12.540	$ 8.435	$ 9.570			$ 12.540
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	4 years 73 days	9 years 127 days	4 years 328 days	8 years 255 days	4 years 73 days
Options Outstanding, Aggregate Intrinsic Value (in Dollars)	$ 858,766		$ 858,766	$ 259,558
Options Grants, Shares			126,500		246,255	113,171
Options Grants, Weighted-Average Exercise Price (in Dollars per share)			$ 6.88		$ 6.500	$ 11.585
Options Grants, Weighted-Average Remaining Contractual Term			10 years		10 years	10 years
Options Grants, Aggregate Intrinsic Value (in Dollars)
Options Exercised, Shares					(8,400)
Options Forfeitures or expirations, Shares					(74,352)	(24,830)
Options Forfeitures or expirations, Weighted-Average Exercise Price (in Dollars per share)					$ 8.115	$ 41.500
Outstanding at December 31, 2014	441,064		565,939	441,055	441,055	277,552	277,552
Outstanding at December 31, 2014 (in Dollars per share)	$ 8.44		$ 8.09	$ 8.435	$ 8.435	$ 9.570	$ 9.570
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	4 years 73 days	9 years 127 days	4 years 328 days	8 years 255 days	4 years 73 days
Outstanding at December 31, 2014 (in Dollars)	$ 858,766		$ 118,486	$ 858,766	$ 858,766	$ 259,558	$ 259,558
Exercisable at December 31, 2014			344,683	227,263	227,263
Exercisable at December 31, 2014 (in Dollars per share)			$ 8.05	$ 8.110	$ 8.110
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1			3 years 255 days		4 years 109 days
Exercisable at December 31, 2014 (in Dollars)			$ 110,570	$ 573,899	$ 573,899

STOCKHOLDERS' EQUITY (Details49

STOCKHOLDERS' EQUITY (Details) - Information related employee stock options - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Number of Options	565,939	441,055
Options Exercisable, Weighted Average Remaining Life	4 years 328 days	4 years 36 days
Options Exercisable, Number of Options	344,683	227,263
Exercise Price Range $0.00 - $5.00 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Number of Options	165,081	157,581
Options Exercisable, Weighted Average Remaining Life	4 years	4 years 219 days
Options Exercisable, Number of Options	149,247	138,831
Exercise Price Range $5.50 - $12.50 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Number of Options		258,074
Options Exercisable, Weighted Average Remaining Life		3 years 255 days
Options Exercisable, Number of Options		67,499
Exercise Price Range $13.00 - $25.00 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Number of Options		15,000
Options Exercisable, Weighted Average Remaining Life		7 years 146 days
Options Exercisable, Number of Options		15,000
Exercise Price Range $25.50 - $45.00 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Number of Options		10,400
Options Exercisable, Weighted Average Remaining Life		5 years 73 days
Options Exercisable, Number of Options		5,933
Minimum [Member] | Exercise Price Range $0.00 - $5.00 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price (in Dollars per share)	$ 0	$ 0
Minimum [Member] | Exercise Price Range $5.50 - $12.50 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price (in Dollars per share)		5.50
Minimum [Member] | Exercise Price Range $13.00 - $25.00 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price (in Dollars per share)		13
Minimum [Member] | Exercise Price Range $25.50 - $45.00 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price (in Dollars per share)		25.50
Maximum [Member] | Exercise Price Range $0.00 - $5.00 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price (in Dollars per share)	$ 5	5
Maximum [Member] | Exercise Price Range $5.50 - $12.50 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price (in Dollars per share)		12.50
Maximum [Member] | Exercise Price Range $13.00 - $25.00 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price (in Dollars per share)		25
Maximum [Member] | Exercise Price Range $25.50 - $45.00 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price (in Dollars per share)		$ 45

STOCKHOLDERS' EQUITY (Details50

STOCKHOLDERS' EQUITY (Details) - Restricted stock activity - Restricted Stock [Member] - shares	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
STOCKHOLDERS' EQUITY (Details) - Restricted stock activity [Line Items]
Restricted shares issued as of January 1, 2013	269,133	269,133
Granted
Total Restricted Shares Issued	269,133	269,133
Vested at December 31, 2014	(225,514)
Unvested restricted shares as of December 31, 2014	43,619

STOCKHOLDERS' EQUITY (Details51

STOCKHOLDERS' EQUITY (Details) - Information with respect to outstanding warrants - $ / shares	12 Months Ended
	Dec. 31, 2014	Jun. 30, 2015	Jan. 01, 2015	Sep. 13, 2013	Apr. 29, 2013	Apr. 19, 2013	Apr. 12, 2012
STOCKHOLDERS' EQUITY (Details) - Information with respect to outstanding warrants [Line Items]
Warrants, Exercise		$ 5	$ 5	$ 2.50			$ 5
Warants, Number Outstanding		220,913	220,913	220,913	220,913	441,826
Warrants Exercise Price $5.00 [Member]
STOCKHOLDERS' EQUITY (Details) - Information with respect to outstanding warrants [Line Items]
Warrants, Exercise	$ 5
Warants, Number Outstanding	220,913
Warrants, Expiration Date	August 2,016

STOCKHOLDERS' EQUITY (Details52

STOCKHOLDERS' EQUITY (Details) - Warrant activity - USD ($)	Jan. 01, 2015	Jan. 01, 2013	Jun. 30, 2015	Dec. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
STOCKHOLDERS' EQUITY (Details) - Warrant activity [Line Items]
ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm	1 year 255 days		1 year 73 days
Warrants Issued/Grants
Warrants Issued/Grants, Aggregate Intrinsic Value (in Dollars)
Warrants Exercised
Warrants Forfeitures or expirations
Outstanding at December 31, 2014	220,913		220,913
Outstanding at December 31, 2014 (in Dollars per share)	$ 5		$ 5
ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm	1 year 255 days		1 year 73 days
Outstanding at December 31, 2014 (in Dollars)	$ 1,325,478		$ 110,457
ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisableNumber			220,913
Exercisable at December 31, 2014 (in Dollars per share)			$ 5
ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisableWeightedAverageRemainingContractualTerm			1 year 73 days
Exercisable at December 31, 2014 (in Dollars)			$ 110,457
Warrant [Member]
STOCKHOLDERS' EQUITY (Details) - Warrant activity [Line Items]
Warrants Outstanding, Share	220,913	649,915	220,913		649,915
Warrants Outstanding, Weighted-Average Exercise Price (in Dollars per share)	$ 2.50	$ 3.85	$ 2.50		$ 3.85
ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm		4 years 146 days		1 year 255 days	3 years 146 days
Warrants Outstanding, Aggregate Intrinsic Value (in Dollars)	$ 1,325,478		$ 1,325,478
Warrants Issued/Grants
Warrants Issued/Grants, Aggregate Intrinsic Value (in Dollars)
Warrants Exercised				(409,823)
Warrants Exercised, Weighted-Average Exercise Price (in Dollars per share)				$ 2.50
Warrants Forfeitures or expirations				(19,179)
Warrants Forfeitures or expirations, Weighted-Average Exercise Price (in Dollars per share)				$ 31
Outstanding at December 31, 2014				220,913	220,913	649,915
Outstanding at December 31, 2014 (in Dollars per share)				$ 2.50	$ 2.50	$ 3.85
ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm		4 years 146 days		1 year 255 days	3 years 146 days
Outstanding at December 31, 2014 (in Dollars)				$ 1,325,478	$ 1,325,478
ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisableNumber				220,913
Exercisable at December 31, 2014 (in Dollars per share)				$ 2.50	$ 2.50
ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisableWeightedAverageRemainingContractualTerm				1 year 255 days
Exercisable at December 31, 2014 (in Dollars)				$ 1,325,478	$ 1,325,478

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details) - USD ($)	Nov. 09, 2012	Jun. 30, 2015	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014	Dec. 31, 2013
RELATED PARTY TRANSACTIONS (Details) [Line Items]
Debt Conversion, Original Debt, Amount	$ 545,958				$ 550,000	$ 2,915,000
Amortization of Debt Discount (Premium)				$ 125,550	223,419	751,126
Aztec [Member]
RELATED PARTY TRANSACTIONS (Details) [Line Items]
Debt Conversion, Original Debt, Amount						522,891
Debt Conversion, Accrued Interest, Amount						$ 30,000
Debt Conversion, Converted Instrument, Shares Issued (in Shares)						73,733
Stock Redeemed or Called During Period, Shares (in Shares)						73,733
Amortization of Debt Discount (Premium)						$ 254,162
Assure [Member]
RELATED PARTY TRANSACTIONS (Details) [Line Items]
Related Party Transaction, Expenses from Transactions with Related Party		$ 6,750	$ 13,500		29,940
Due to Related Parties		4,500	4,500		2,250
Payments for Fees					95,000
Merriman [Member]
RELATED PARTY TRANSACTIONS (Details) [Line Items]
Related Party Transaction, Expenses from Transactions with Related Party		$ 30,000	$ 60,000		$ 120,000

COMMITMENTS AND CONTINGENCIES54

COMMITMENTS AND CONTINGENCIES (Details) - USD ($)	Dec. 15, 2014	Oct. 01, 2012	Dec. 31, 2014	Dec. 31, 2013
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]
Lease Expiration Date	Dec. 15, 2017	Sep. 30, 2015
Lessee Leasing Arrangements, Operating Leases, Term of Contract	3 years	3 years
Operating Leases, Rent Expense	$ 1,235	$ 1,345	$ 51,114	$ 36,857
Lease and Rental Expenses, Frequency of Periodic Payment	per month	per month
Lease And Rental Expenses Percentage Increase	3.50%	3.50%
Security Deposit	$ 1,235	$ 1,345
Settlement And License Agreement [Member]
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]
Royalty			3.50%

COMMITMENTS AND CONTINGENCIES55

COMMITMENTS AND CONTINGENCIES (Details) - Schedule of future minimum lease payments	Dec. 31, 2014USD ($)
Schedule of future minimum lease payments [Abstract]
2,015	$ 28,255
2,016	15,355
2,017	15,208
Total	$ 58,818

INCOME TAXES (Details)

INCOME TAXES (Details) - USD ($)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
INCOME TAXES (Details) [Line Items]
Deferred Tax Assets, Operating Loss Carryforwards, Domestic	$ 13,081,670	$ 9,533,943
Minimum [Member]
INCOME TAXES (Details) [Line Items]
Operating Loss Carryforwards, Expiration Year	2,030
Maximum [Member]
INCOME TAXES (Details) [Line Items]
Operating Loss Carryforwards, Expiration Year	2,034

INCOME TAXES (Details) - The ta

INCOME TAXES (Details) - The tax effects of temporary differences that give rise to deferred tax assets - USD ($)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Deferred Tax Assets:
Net operating loss carryforward	$ 4,447,768	$ 3,327,518
Stock-based compensation	2,205,340	1,862,399
Total deferred tax assets	6,653,108	5,189,917
Valuation allowance	$ (6,653,108)	$ (5,189,917)
Deferred tax asset, net of valuation allowance
Changes in valuation allowance	$ 1,463,191	$ 2,246,450

INCOME TAXES (Details) - The in

INCOME TAXES (Details) - The income tax provision (benefit) - USD ($)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Federal:
Current
Deferred	$ (1,463,191)	$ (2,246,450)
State and local:
Current
Deferred
Current Income Tax Expense (Benefit), Total	$ (1,463,191)	$ (2,246,450)
Change in valuation allowance	$ 1,463,191	$ 2,246,450
Income tax provision (benefit)

INCOME TAXES (Details) - A reco

INCOME TAXES (Details) - A reconciliation of the statutory federal income tax rate to the Company`s effective tax rate	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
A reconciliation of the statutory federal income tax rate to the Company`s effective tax rate [Abstract]
Tax benefit at federal statutory rate	(34.00%)	(34.00%)
Other non-deductible compensation subject to SEC 162(M)	10.10%	0.00%
Permanent differences	5.00%	1.10%
Change in valuation allowance	18.90%	32.90%
Effective income tax rate	0.00%	0.00%

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details) - USD ($)	Jul. 20, 2015	Jul. 02, 2015	Mar. 12, 2015	Nov. 09, 2012	Jul. 20, 2015	Jan. 17, 2016	Aug. 17, 2015
SUBSEQUENT EVENTS (Details) [Line Items]
Conversion of Stock, Shares Issued (in Shares)				74,669
Debt Instrument, Interest Rate, Stated Percentage				8.00%
Subsequent Event [Member]
SUBSEQUENT EVENTS (Details) [Line Items]
Conversion of Stock, Shares Issued (in Shares)		5,013,366	47,646
Debt Instrument, Face Amount (in Dollars)	$ 550,000				$ 550,000
Proceeds from Issuance of Debt (in Dollars)					$ 500,000
Debt Instrument, Maturity Period	1 year
Debt Instrument, Interest Rate, Stated Percentage						10.00%
Debt Instrument, Convertible, Conversion Price (in Dollars per share)						$ 7.5321
Debt Instrument, Prepayment Price, Discount Rate					20.00%
Debt Instrument, Convertible, Threshold Consecutive Trading Days					3 years
Debt Instrument, Cash Prepayment, Premium Rate					120.00%
Royalty fee percentage							4.125%

SUMMARY OF SIGNIFICANT ACCOUN61

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Potentially dilutive securities excluded from the computation of basic and diluted net loss per share - shares	6 Months Ended		12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014	Dec. 31, 2013
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities excluded from the computation of basic and diluted net income (loss) per share	786,852	1,127,254	753,253	1,477,512
Restricted Stock Units (RSUs) [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities excluded from the computation of basic and diluted net income (loss) per share		88,843	43,619	269,133
Series A Preferred Stock [Member] | Convertible Debt Securities [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities excluded from the computation of basic and diluted net income (loss) per share		220,913	47,666	220,913
Common Stock [Member] | Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities excluded from the computation of basic and diluted net income (loss) per share	565,939	517,406
Common Stock [Member] | Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities excluded from the computation of basic and diluted net income (loss) per share	220,913	240,092
Convertible Notes Payable [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities excluded from the computation of basic and diluted net income (loss) per share		60,000		60,000

STOCKHOLDERS' EQUITY (Details62

STOCKHOLDERS' EQUITY (Details) - Assumptions used in determining fair value of employee and vesting non-employee options - $ / shares	6 Months Ended		12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014	Dec. 31, 2013
STOCKHOLDERS' EQUITY (Details) - Assumptions used in determining fair value of employee and vesting non-employee options [Line Items]
Dividend yield	0.00%	0.00%	0.00%	0.00%
Weighted average grant date fair value (in Dollars per share)	$ 5.98	$ 5.50	$ 5.50	$ 5.50
Minimum [Member]
STOCKHOLDERS' EQUITY (Details) - Assumptions used in determining fair value of employee and vesting non-employee options [Line Items]
Risk-free interest rate	1.68%	2.13%	1.97%	0.62%
Stock price volatility	123.45%	77.60%	76.00%	35.00%
Expected life	5 years	8 years	6 years	6 years
Maximum [Member]
STOCKHOLDERS' EQUITY (Details) - Assumptions used in determining fair value of employee and vesting non-employee options [Line Items]
Risk-free interest rate	2.07%	2.73%	2.73%	0.86%
Stock price volatility	145.24%	79.20%	79.00%	118.00%
Expected life	10 years	10 years	10 years	10 years

STOCKHOLDERS' EQUITY (Details63

STOCKHOLDERS' EQUITY (Details) - Stock option activity - USD ($)	Jan. 01, 2015	Jan. 01, 2013	Jun. 30, 2015	Dec. 31, 2014	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Stock option activity [Abstract]
Outstanding at January 1, 2015	441,064		565,939	441,055	441,055	277,552	189,211
Outstanding at January 1, 2015	$ 8.44		$ 8.09	$ 8.435	$ 8.435	$ 9.570	$ 12.540
Outstanding at January 1, 2015	4 years 73 days	9 years 127 days	4 years 328 days	8 years 255 days	4 years 73 days
Outstanding at January 1, 2015	$ 858,766		$ 118,486	$ 858,766	$ 858,766	$ 259,558
Granted			126,500		246,255	113,171
Granted			$ 6.88		$ 6.500	$ 11.585
Granted			10 years		10 years	10 years
Canceled/expired			(1,625)
Canceled/expired			$ 5.73
Outstanding at June 30, 2015	441,064		565,939	441,055	441,055	277,552	189,211
Outstanding at June 30, 2015	$ 8.44		$ 8.09	$ 8.435	$ 8.435	$ 9.570	$ 12.540
Outstanding at June 30, 2015	4 years 73 days	9 years 127 days	4 years 328 days	8 years 255 days	4 years 73 days
Outstanding at June 30, 2015	$ 858,766		$ 118,486	$ 858,766	$ 858,766	$ 259,558
Exercisable at June 30, 2015			344,683	227,263	227,263
Exercisable at June 30, 2015			$ 8.05	$ 8.110	$ 8.110
Exercisable at June 30, 2015			3 years 255 days		4 years 109 days
Exercisable at June 30, 2015			$ 110,570	$ 573,899	$ 573,899

STOCKHOLDERS' EQUITY (Details64

STOCKHOLDERS' EQUITY (Details) - Information related employee stock options - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Number of Options	565,939	441,055
Options Exercisable, Weighted Average Remaining Life	4 years 328 days	4 years 36 days
Options Exercisable, Number of Options	344,683	227,263
Exercise Price Range $0.00 - $5.00 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Number of Options	165,081	157,581
Options Exercisable, Weighted Average Remaining Life	4 years	4 years 219 days
Options Exercisable, Number of Options	149,247	138,831
Exercise Price Range $5.01 - $12.50 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Number of Options	375,449
Options Exercisable, Weighted Average Remaining Life	5 years 109 days
Options Exercisable, Number of Options	174,494
Exercise Price Range $12.51 - $25.00 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Number of Options	15,008
Options Exercisable, Weighted Average Remaining Life	4 years 255 days
Options Exercisable, Number of Options	15,008
Exercise Price Range $25.01 - $45.00 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Number of Options	10,401
Options Exercisable, Weighted Average Remaining Life	4 years 255 days
Options Exercisable, Number of Options	5,934
Minimum [Member] | Exercise Price Range $0.00 - $5.00 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price (in Dollars per share)	$ 0	$ 0
Minimum [Member] | Exercise Price Range $5.01 - $12.50 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price (in Dollars per share)	5.01
Minimum [Member] | Exercise Price Range $12.51 - $25.00 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price (in Dollars per share)	12.51
Minimum [Member] | Exercise Price Range $25.01 - $45.00 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price (in Dollars per share)	25.01
Maximum [Member] | Exercise Price Range $0.00 - $5.00 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price (in Dollars per share)	5	$ 5
Maximum [Member] | Exercise Price Range $5.01 - $12.50 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price (in Dollars per share)	12.50
Maximum [Member] | Exercise Price Range $12.51 - $25.00 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price (in Dollars per share)	25
Maximum [Member] | Exercise Price Range $25.01 - $45.00 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price (in Dollars per share)	$ 45

STOCKHOLDERS' EQUITY (Details65

STOCKHOLDERS' EQUITY (Details) - Warrant activity - USD ($)	Jan. 01, 2015	Jun. 30, 2015	Sep. 13, 2013	Apr. 29, 2013	Apr. 19, 2013	Apr. 12, 2012
Warrant activity [Abstract]
Outstanding at January 1, 2015	220,913	220,913	220,913	220,913	441,826
Outstanding at January 1, 2015 (in Dollars per share)	$ 5	$ 5	$ 2.50			$ 5
Outstanding at January 1, 2015	1 year 255 days	1 year 73 days
Outstanding at January 1, 2015 (in Dollars)	$ 1,325,478	$ 110,457
Grants
Grants (in Dollars)
Exercised
Forfeitures or expirations
Outstanding at June 30, 2015	220,913	220,913	220,913	220,913	441,826
Outstanding at June 30, 2015 (in Dollars per share)	$ 5	$ 5	$ 2.50			$ 5
Outstanding at June 30, 2015	1 year 255 days	1 year 73 days
Outstanding at June 30, 2015 (in Dollars)	$ 1,325,478	$ 110,457
Exercisable at June 30, 2015		220,913
Exercisable at June 30, 2015 (in Dollars per share)		$ 5
Exercisable at June 30, 2015		1 year 73 days
Exercisable at June 30, 2015 (in Dollars)		$ 110,457